Hypertension literature — master bibliography

Last updated: 2026-09-01

Every PMID used anywhere in the hypertension condition is listed once below — 785 distinct records. All were resolved through live PubMed E-utilities queries during the build session of 2026-09-01; the metadata in this file was regenerated programmatically from those live summaries rather than transcribed by hand. Entries are grouped by the first major domain that cites them, while cited by preserves every file that uses the record. ClinicalTrials.gov identifiers are catalogued in wiki/clinical-trials-landscape.md rather than here.

Two records carry publication flags and are tagged accordingly: PMID 29669232 is a retracted publication and appears in this knowledge base only as an explicit exclusion, never as evidence; PMID 31641769 carries a journal Expression of Concern (PMID 32318736) and is presented only as a contested claim.

Overview, definitions and guidelines

• ACCORD Study Group, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-85. PMID 20228401 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Adler GK, et al. Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2025;110:2453-2495. PMID 40658480 — tags: [hypertension, guideline] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/notes/brown-2020-unrecognized-aldosteronism.md, wiki/guidelines.md, wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md, wiki/secondary-hypertension.md
• Al-Makki A, et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2022;79:293-301. PMID 34775787 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/overview.md
• Anderson TS, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023;183:715-723. PMID 37252732 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/guidelines.md, wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md
• Andreadis EA, et al. Attended Versus Unattended Automated Office Blood Pressure: A Systematic Review and Meta-analysis. High Blood Press Cardiovasc Prev. 2019;26:293-303. PMID 31290085 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/notes/sprint-2015-intensive-control.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/red-flags-and-safety-concerns.md
• Anstey DE, et al. USPSTF Recommendation Statement on Hypertension Screening in Adults-Where Do We Go From Here?. JAMA Netw Open. 2021;4:e214203. PMID 33904916 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Appel LJ, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-24. PMID 9099655 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md
• Beckett NS, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-98. PMID 18378519 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/overview.md, wiki/special-populations.md
• Bhatt DL, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-401. PMID 24678939 — tags: [hypertension, rct] — cited by: literature/guidelines/REGISTRY.md, literature/notes/bhatt-2014-symplicity-htn3.md, literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md, wiki/overview.md — note: notes/bhatt-2014-symplicity-htn3.md
• Bi Y, et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med. 2025;392:1155-1167. PMID 39555827 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/notes/sprint-2015-intensive-control.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Blood Pressure Lowering Treatment Trialists' Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. 2021;398:1053-1064. PMID 34461040 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/notes/bpltcc-2021-across-bp-levels.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/special-populations.md
• Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625-1636. PMID 33933205 — tags: [hypertension, meta-analysis] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/notes/bpltcc-2021-across-bp-levels.md, literature/statistics/STATISTICS.md, wiki/overview.md, wiki/risk-and-outcomes.md — note: notes/bpltcc-2021-across-bp-levels.md
• Brown JM, et al. The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. Ann Intern Med. 2020;173:10-20. PMID 32449886 — tags: [hypertension, primary] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/notes/brown-2020-unrecognized-aldosteronism.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/guidelines.md, wiki/overview.md, wiki/pathophysiology.md, wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md, wiki/secondary-hypertension.md — note: notes/brown-2020-unrecognized-aldosteronism.md
• Böhm M, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395:1444-1451. PMID 32234534 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/notes/bhatt-2014-symplicity-htn3.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/device-and-interventional-therapy.md, wiki/overview.md, wiki/pathophysiology.md
• Caillon A, et al. Role of immune cells in hypertension. Br J Pharmacol. 2019;176:1818-1828. PMID 29952002 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/overview.md, wiki/pathophysiology.md
• Campbell NRC, et al. 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas. Lancet Reg Health Am. 2022;9:None. PMID 35711684 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/adherence-and-implementation.md, wiki/guidelines.md
• Canales MT, et al. As-Needed Blood Pressure Medication and Adverse Outcomes in VA Hospitals. JAMA Intern Med. 2025;185:52-60. PMID 39585709 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/guidelines.md, wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md
• Carey RM, et al. Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018;168:351-358. PMID 29357392 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Carriazo S, et al. Blood pressure targets in CKD 2021: the never-ending guidelines debacle. Clin Kidney J. 2022;15:845-851. PMID 35498896 — tags: [hypertension, primary] — cited by: wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/special-populations.md
• Charchar FJ, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42:23-49. PMID 37712135 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/guidelines.md
• Cheung AK, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99:559-569. PMID 33637203 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/special-populations.md
• Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. PMID 12748199 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Chow CK, et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Lancet. 2021;398:1043-1052. PMID 34469767 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/guidelines.md, wiki/overview.md, wiki/patient-experience-and-advocacy.md, wiki/pharmacological-therapy.md
• Desai AS, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023;389:228-238. PMID 37467498 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/overview.md, wiki/pathophysiology.md, wiki/pharmacological-therapy.md
• Eguchi K, et al. Validity of risk stratification of JSH 2025 guideline based on hypertensive retinal changes. Hypertens Res. 2026;49:1632-1638. PMID 41792247 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md
• ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925-38. PMID 24107724 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Esler M. The sympathetic nervous system in hypertension: back to the future?. Curr Hypertens Rep. 2015;17:11. PMID 25680900 — tags: [hypertension, review] — cited by: wiki/overview.md, wiki/pathophysiology.md
• Evans RG, et al. Role of the kidney in the pathogenesis of hypertension: time for a neo-Guytonian paradigm or a paradigm shift?. Am J Physiol Regul Integr Comp Physiol. 2016;310:R217-29. PMID 26582636 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/overview.md, wiki/pathophysiology.md
• Flack JM, et al. Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. N Engl J Med. 2025;393:1363-1374. PMID 40888730 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/overview.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Flynn JT, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140. PMID 28827377 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md, wiki/special-populations.md
• Freeman MW, et al. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. N Engl J Med. 2023;388:395-405. PMID 36342143 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/overview.md, wiki/pathophysiology.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223-1249. PMID 33069327 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/overview.md
• GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406:1873-1922. PMID 41092926 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/overview.md
• Geldsetzer P, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019;394:652-662. PMID 31327566 — tags: [hypertension, meta-analysis] — cited by: literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md, wiki/overview.md
• Goupil R, et al. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care. CMAJ. 2025;197:E549-E564. PMID 40419299 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/adherence-and-implementation.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md
• Guo X, et al. Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials. Lancet. 2025;406:1009-1019. PMID 40902616 — tags: [hypertension, systematic-review, review] — cited by: INDEX.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md
• Guyton AC, et al. Salt balance and long-term blood pressure control. Annu Rev Med. 1980;31:15-27. PMID 6994602 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/overview.md, wiki/pathophysiology.md
• Hall JE, et al. Regulation of arterial pressure: role of pressure natriuresis and diuresis. Fed Proc. 1986;45:2897-903. PMID 3536587 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/overview.md, wiki/pathophysiology.md
• Hoshide S, et al. Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients. J Clin Hypertens (Greenwich). 2020;22:369-377. PMID 31891452 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Hu JR, et al. The Promise and Illusion of Continuous, Cuffless Blood Pressure Monitoring. Curr Cardiol Rep. 2023;25:1139-1149. PMID 37688763 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/overview.md
• Huang L, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368:m315. PMID 32094151 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md
• Hutchinson B, et al. Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-points. BMJ Open. 2024;14:e071036. PMID 38626959 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/guidelines.md
• Imai Y, et al. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003;26:771-82. PMID 14621179 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Jaffe MG, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310:699-705. PMID 23989679 — tags: [hypertension, primary] — cited by: literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/overview.md
• James PA, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20. PMID 24352797 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res. 2006;29 Suppl:S1-105. PMID 17366911 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Jones DW, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025;86:1567-1678. PMID 40815242 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Jones NR, et al. Diagnosis and management of hypertension in adults: NICE guideline update 2019. Br J Gen Pract. 2020;70:90-91. PMID 32001477 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Kario K. Key Points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014. Pulse (Basel). 2015;3:35-47. PMID 26587456 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Kario K. Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension. Korean Circ J. 2019;49:1123-1135. PMID 31760704 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Kario K, et al. Guidelines for the appropriate use of renal denervation systems in Japan: endorsed by the Japanese Society of Hypertension (JSH), the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS), and their positioning in the JSH 2025 guidelines. Hypertens Res. 2026;49:1815-1824. PMID 42002632 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99:S1-S87. PMID 33637192 — tags: [hypertension, guideline] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/special-populations.md
• Kikuchi T. Pediatric hypertension based on Japanese Society of Hypertension Guidelines (JSH 2019) with actual school blood pressure screening data in Japan. Clin Exp Pediatr. 2022;65:283-290. PMID 34844400 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md
• Kirtane AJ, et al. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. JAMA Cardiol. 2023;8:464-473. PMID 36853627 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/notes/bhatt-2014-symplicity-htn3.md, literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md, wiki/overview.md
• Koga M. Blood pressure management in stroke: comparative review of the 2025 AHA/ACC/AANP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM, 2024 ESC, 2023 ESH, and 2025 JSH guidelines. Hypertens Res. 2026;49:984-987. PMID 41514030 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Kreutz R, et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1-15. PMID 38914505 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Kurtz TW, et al. Logical Issues With the Pressure Natriuresis Theory of Chronic Hypertension. Am J Hypertens. 2016;29:1325-1331. PMID 28637271 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/overview.md, wiki/pathophysiology.md
• Lenfant C, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003;41:1178-9. PMID 12756222 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md
• Lewington S, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13. PMID 12493255 — tags: [hypertension, meta-analysis] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/overview.md, wiki/pathophysiology.md, wiki/risk-and-outcomes.md
• Li S, et al. Estimated Prevalence of Masked Asleep Hypertension in US Adults. JAMA Cardiol. 2021;6:568-573. PMID 33112362 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md
• Lifton RP, et al. Molecular mechanisms of human hypertension. Cell. 2001;104:545-56. PMID 11239411 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/overview.md, wiki/pathophysiology.md
• Liu J. Highlights of the 2024 Chinese hypertension guidelines. Hypertens Res. 2025;48:1048-1053. PMID 39762483 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Liu J, et al. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet. 2024;404:245-255. PMID 38945140 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/notes/sprint-2015-intensive-control.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/guidelines.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Mancia G, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-357. PMID 23817082 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Mancia G, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-219. PMID 23771844 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Mancia G, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014;23:3-16. PMID 24359485 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md
• Mancia G, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874-2071. PMID 37345492 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md
• McCormack T, et al. Management of hypertension in adults in primary care: NICE guideline. Br J Gen Pract. 2012;62:163-4. PMID 22429432 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912-4018. PMID 39210715 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md
• Moick S, et al. [WHO Guideline for the Pharmacological Treatment of Hypertension in Adults]. Gesundheitswesen. 2023;85:139-142. PMID 36791691 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Muntner P, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137:109-118. PMID 29133599 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, literature/notes/ncdrisc-2021-worldwide-trends.md, literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/guidelines.md, wiki/overview.md
• Muntner P, et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324:1190-1200. PMID 32902588 — tags: [hypertension, primary] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/blood-pressure-targets.md, wiki/epidemiology-and-burden.md, wiki/overview.md
• Naci H, et al. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure. Br J Sports Med. 2019;53:859-869. PMID 30563873 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md
• National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. Royal College of Physicians (UK). 2011. PMID 22855971 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md
• National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. National Institute for Health and Care Excellence (NICE). 2026. PMID 31577399 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957-980. PMID 34450083 — tags: [hypertension, primary] — cited by: INDEX.md, literature/notes/ncdrisc-2021-worldwide-trends.md, literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md, wiki/overview.md — note: notes/ncdrisc-2021-worldwide-trends.md
• Neal B, et al. Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med. 2021;385:1067-1077. PMID 34459569 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/notes/neal-2021-salt-substitution.md, literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md — note: notes/neal-2021-salt-substitution.md
• Rabi DM, et al. Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2020;36:596-624. PMID 32389335 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Rastogi R, et al. Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. JAMA Intern Med. 2021;181:345-352. PMID 33369614 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/guidelines.md, wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md
• Reboussin DM, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e116-e135. PMID 29133355 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Reboussin DM, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2176-2198. PMID 29146534 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/guidelines/REGISTRY.md
• Reboussin DM, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e595-e616. PMID 30354656 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/guidelines/REGISTRY.md
• Roerecke M, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e108-e120. PMID 29253389 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md
• Sacks FM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10. PMID 11136953 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/overview.md
• Sarafidis P, et al. A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension. Nephrol Dial Transplant. 2024;39:929-943. PMID 38365947 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Saruta T. [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)]. Nihon Rinsho. 2005;63:952-8. PMID 15948375 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Satheesh G, et al. Standardized treatment protocols for hypertension: global availability, characteristics, and alignment with the hypertension guideline recommendations. J Hypertens. 2024;42:902-908. PMID 38108382 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md, wiki/guidelines.md
• Schild L, et al. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J. 1996;15:2381-7. PMID 8665845 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/overview.md, wiki/pathophysiology.md
• Schlaich MP, et al. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Lancet. 2022;400:1927-1937. PMID 36356632 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/overview.md, wiki/pathophysiology.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Schmieder RE, et al. Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention. 2013;9 Suppl R:R58-66. PMID 23732157 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md
• Schwalm JD, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019;394:1231-1242. PMID 31488369 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/clinical-trials-landscape.md, wiki/overview.md
• Shibata S, et al. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc Natl Acad Sci U S A. 2013;110:7838-43. PMID 23576762 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/overview.md, wiki/pathophysiology.md
• SPRINT MIND Investigators for the SPRINT Research Group, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321:553-561. PMID 30688979 — tags: [hypertension, rct] — cited by: literature/notes/sprint-2015-intensive-control.md
• SPRINT MIND Investigators for the SPRINT Research Group, et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019;322:524-534. PMID 31408137 — tags: [hypertension, rct] — cited by: literature/notes/sprint-2015-intensive-control.md
• SPRINT Research Group, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373:2103-16. PMID 26551272 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/notes/sprint-2015-intensive-control.md, wiki/blood-pressure-targets.md, wiki/overview.md — note: notes/sprint-2015-intensive-control.md
• SPRINT Research Group, et al. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021;384:1921-1930. PMID 34010531 — tags: [hypertension, rct] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/notes/sprint-2015-intensive-control.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md, wiki/risk-and-outcomes.md
• Staessen JA, et al. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit. 2001;6:355-70. PMID 12055415 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Stergiou GS, et al. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens. 2023;41:2074-2087. PMID 37303198 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md, wiki/red-flags-and-safety-concerns.md
• Sun Y, et al. A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial. Lancet. 2022;399:1964-1975. PMID 35500594 — tags: [hypertension, rct] — cited by: INDEX.md, OPEN-QUESTIONS.md, literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/clinical-trials-landscape.md, wiki/overview.md — note: notes/sun-2022-village-doctor.md
• Touyz RM. Hypertension Guidelines: Effect of Blood Pressure Targets. Can J Cardiol. 2019;35:564-569. PMID 31030859 — tags: [hypertension, primary] — cited by: wiki/blood-pressure-targets.md, wiki/guidelines.md
• Toyoda K. Blood pressure management for stroke patients beyond the JSH 2025 guidelines. Hypertens Res. 2026. PMID 42660977 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Umemura S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235-1481. PMID 31375757 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Unger T, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334-1357. PMID 32370572 — tags: [hypertension, guideline] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md
• US Preventive Services Task Force, et al. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2021;325:1650-1656. PMID 33904861 — tags: [hypertension, guideline] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/guidelines.md, wiki/red-flags-and-safety-concerns.md
• Vasan RS, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287:1003-10. PMID 11866648 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/overview.md, wiki/risk-and-outcomes.md
• Vasan RS, et al. Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study. Hypertension. 2022;79:1045-1056. PMID 35168368 — tags: [hypertension, primary] — cited by: wiki/overview.md, wiki/pathophysiology.md
• Victor RG, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018;378:1291-1301. PMID 29527973 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/clinical-trials-landscape.md, wiki/overview.md, wiki/patient-experience-and-advocacy.md
• Webster R, et al. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial. JAMA. 2018;320:566-579. PMID 30120478 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/guidelines.md, wiki/overview.md, wiki/pharmacological-therapy.md
• Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-e115. PMID 29133356 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2199-2269. PMID 29146533 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269-1324. PMID 29133354 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248. PMID 29146535 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md
• Williams B, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059-2068. PMID 26414968 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md, wiki/guidelines.md, wiki/overview.md, wiki/pharmacological-therapy.md, wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md
• Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-3104. PMID 30165516 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md
• Williams B, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953-2041. PMID 30234752 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md
• Wiysonge CS, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:CD002003. PMID 28107561 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/guidelines.md, wiki/overview.md, wiki/pharmacological-therapy.md
• Wright JM, et al. First-line drugs for hypertension. Cochrane Database Syst Rev. 2018;4:CD001841. PMID 29667175 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/guidelines.md, wiki/pharmacological-therapy.md
• Writing Committee Members*, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025;82:e212-e316. PMID 40811516 — tags: [hypertension, guideline, review] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md, wiki/guidelines.md, wiki/overview.md
• Writing Committee Members*, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152:e114-e218. PMID 40811497 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/guidelines.md
• Zhou B, et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785-802. PMID 34050340 — tags: [hypertension, review] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/overview.md

Epidemiology, burden and the care cascade

• Aggarwal R, et al. Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020. JAMA. 2023;329:899-909. PMID 36871237 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md
• Ataklte F, et al. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2015;65:291-8. PMID 25385758 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/patient-voice/organizations.md, literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md
• Atkins ER, et al. The cost of treating hypertension in Australia, 2012-22: an economic analysis. Med J Aust. 2024;221:612-616. PMID 39580704 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Aytenew TM, et al. Uncontrolled hypertension among hypertensive patients in Sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2024;19:e0301547. PMID 38870163 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/epidemiology-and-burden.md
• Baker-Smith CM. Tracking of blood pressure levels from childhood. Pediatr Nephrol. 2025;40:367-376. PMID 39196350 — tags: [hypertension, review] — cited by: wiki/epidemiology-and-burden.md
• Blazel MM, et al. Neighborhood-Level Disparities in Hypertension Prevalence and Treatment Among Middle-Aged Adults. JAMA Netw Open. 2024;7:e2429764. PMID 39177999 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/special-populations.md
• Cao X, et al. Trends and sociodemographic patterns in hypertension prevalence and treatment in China. Med. 2025;6:100808. PMID 40865522 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Chen A, et al. Hypertension among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis. Sci Rep. 2024;14:16858. PMID 39039244 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/epidemiology-and-burden.md, wiki/special-populations.md
• Chen X, et al. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117:3171-80. PMID 18559702 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/risk-and-outcomes.md
• Daroudi R, et al. Economic burden of hypertension in Iran: a prevalence-based cost of illness study. BMJ Open. 2025;15:e099322. PMID 40484429 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Davies JI, et al. Association between country preparedness indicators and quality clinical care for cardiovascular disease risk factors in 44 lower- and middle-income countries: A multicountry analysis of survey data. PLoS Med. 2020;17:e1003268. PMID 33170842 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md
• Dixon DL, et al. Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States. JAMA Netw Open. 2023;6:e2341408. PMID 37921763 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md
• Egan BM, et al. Trends in Hypertension Control Among United States Adults: Is NHANES the Outlier?. Hypertension. 2023;80:2544-2546. PMID 37967159 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md
• GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23:973-1003. PMID 39304265 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• He S, et al. State-Level Hypertension Prevalence and Control Among Adults in the U.S. Am J Prev Med. 2024;66:46-54. PMID 37877903 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Iiskala F, et al. Life-Course Blood Pressure Levels, 38-Year Tracking, and Prediction of Hypertension. J Am Heart Assoc. 2026;15:e041805. PMID 41431974 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Isaac Derick K, et al. Prevalence, Awareness, Treatment, Control of Hypertension, and Availability of Hypertension Services for Patients Living With Human Immunodeficiency Virus (HIV) in Sub-Saharan Africa (SSA): A Systematic Review and Meta-analysis. Cureus. 2023;15:e37422. PMID 37182060 — tags: [hypertension, review] — cited by: wiki/epidemiology-and-burden.md
• Ji H, et al. Sex Differences in Blood Pressure Trajectories Over the Life Course. JAMA Cardiol. 2020;5:19-26. PMID 31940010 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/epidemiology-and-burden.md
• Ji H, et al. Sex Differences in Myocardial and Vascular Aging. Circ Res. 2022;130:566-577. PMID 35175845 — tags: [hypertension, review] — cited by: wiki/epidemiology-and-burden.md
• Lee HH, et al. Trends in Prevalence, Treatment, and Control of Cardiometabolic Risk Factors Among Adults With Hypertension in the United States, 1999-2023. J Am Coll Cardiol. 2025;86:2577-2593. PMID 41295934 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md
• Li F, et al. Cardiovascular Disease Attributable to High Systolic Blood Pressure in Younger Adults Requires Greater Attention: Insights from the Global Burden of Disease Study 2021. J Am Heart Assoc. 2025;14:e041964. PMID 40497517 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Meng Y, et al. Tracking and Transition Probability of Blood Pressure From Childhood to Midadulthood. JAMA Pediatr. 2025;179:34-45. PMID 39495520 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md, wiki/risk-and-outcomes.md, wiki/special-populations.md
• Mills KT, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134:441-50. PMID 27502908 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md
• Mohamed SF, et al. Prevalence of uncontrolled hypertension in people with comorbidities in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open. 2021;11:e045880. PMID 34903530 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/epidemiology-and-burden.md
• O'Connell SS, et al. Global trends in hypertension prevalence, awareness, treatment, and control. Curr Opin Nephrol Hypertens. 2026;35:174-180. PMID 41495934 — tags: [hypertension, review] — cited by: wiki/epidemiology-and-burden.md
• Qiu W, et al. Hypertension awareness, treatment, control, and prognosis: insights from the sub-cohort of China PEACE million persons project. Hypertens Res. 2025;48:1012-1023. PMID 39639124 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Seeley A, et al. Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis. BMC Med. 2020;18:75. PMID 32216794 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/epidemiology-and-burden.md, wiki/pharmacological-therapy.md
• Shangguan S, et al. Endogenous and exogenous determinants of sex differences in blood pressure. NPJ Cardiovasc Health. 2026;3. PMID 42185679 — tags: [hypertension, review] — cited by: wiki/epidemiology-and-burden.md
• Stein DT, et al. Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries. Nat Med. 2024;30:414-423. PMID 38278990 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/epidemiology-and-burden.md
• Tang R, et al. Trends in Hypertension Prevalence, Awareness, Treatment, and Control Among US Young Adults, 2003-2023. Am J Hypertens. 2025;38:551-559. PMID 40156902 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/epidemiology-and-burden.md, wiki/special-populations.md
• Urbina EM, et al. Relation of Blood Pressure in Childhood to Self-Reported Hypertension in Adulthood. Hypertension. 2019;73:1224-1230. PMID 31067199 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md
• Wills AK, et al. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med. 2011;8:e1000440. PMID 21695075 — tags: [hypertension, primary] — cited by: wiki/epidemiology-and-burden.md

Measurement, diagnosis and blood-pressure phenotypes

• Armstrong D, et al. Automated office blood pressure - being alone and not location is what matters most. Blood Press Monit. 2015;20:204-8. PMID 26154710 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Asayama K, et al. What did we learn from the International Databases on Ambulatory and Home Blood Pressure in Relation to Cardiovascular Outcome?. Hypertens Res. 2023;46:934-949. PMID 36737461 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Babu M, et al. Masked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events. Curr Cardiol Rep. 2019;21:58. PMID 31111326 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/special-populations.md
• Banegas JR, et al. Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality. N Engl J Med. 2018;378:1509-1520. PMID 29669232 — tags: [hypertension, RETRACTED — not used as evidence] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md
• Bauer F, et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71:243-249. PMID 29255074 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Borrelli S, et al. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD. Am J Kidney Dis. 2023;81:15-24.e1. PMID 35709922 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/special-populations.md
• Bradley CK, et al. Cuffless Blood Pressure Devices. Am J Hypertens. 2022;35:380-387. PMID 35136906 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Briasoulis A, et al. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens. 2016;34:593-9. PMID 26734955 — tags: [hypertension, meta-analysis, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Cheng YB, et al. Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension. Hypertension. 2019;74:776-783. PMID 31378104 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Chrysant SG. The clinical significance of isolated diastolic hypertension. Postgrad Med. 2020;132:624-628. PMID 32594846 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Cohen JB, et al. Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis. Ann Intern Med. 2019;170:853-862. PMID 31181575 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md
• Etyang AO, et al. Diagnostic Accuracy of Unattended Automated Office Blood Pressure Measurement in Screening for Hypertension in Kenya. Hypertension. 2019;74:1490-1498. PMID 31587589 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Fagard RH, et al. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193-8. PMID 17921809 — tags: [hypertension, meta-analysis] — cited by: wiki/definition-measurement-and-diagnosis.md
• Fang J, et al. Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects. Hypertension. 1995;26:377-82. PMID 7649569 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Filipovský J, et al. A multicentre study on unattended automated office blood pressure measurement in treated hypertensive patients. Blood Press. 2018;27:188-193. PMID 29334262 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Foti KE, et al. Digit Preference in Office Blood Pressure Measurements, United States 2015-2019. Am J Hypertens. 2021;34:521-530. PMID 33246327 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Franklin SS, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564-71. PMID 22252396 — tags: [hypertension, meta-analysis, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Gallagher BD, et al. Pitfalls of Cuff Size and Blood Pressure Measurement. JAMA Intern Med. 2024;184:448-449. PMID 38372976 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Green BB, et al. Automated Office Blood Pressure and the Impact of Attendance and Rest on Diagnostic Accuracy. Am J Hypertens. 2022;35:638-646. PMID 35240678 — tags: [hypertension, rct] — cited by: wiki/definition-measurement-and-diagnosis.md
• Hansen TW, et al. Ambulatory blood pressure and mortality: a population-based study. Hypertension. 2005;45:499-504. PMID 15753229 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Hessel PA. Terminal digit preference in blood pressure measurements: effects on epidemiological associations. Int J Epidemiol. 1986;15:122-5. PMID 3957533 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Huang Y, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677-688. PMID 28253216 — tags: [hypertension, meta-analysis, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Huart J, et al. Pathophysiology of the Nondipping Blood Pressure Pattern. Hypertension. 2023;80:719-729. PMID 36606502 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Ishigami J, et al. Effects of Cuff Size on the Accuracy of Blood Pressure Readings: The Cuff(SZ) Randomized Crossover Trial. JAMA Intern Med. 2023;183:1061-1068. PMID 37548984 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Ishigami J, et al. Pitfalls of Cuff Size and Blood Pressure Measurement-Reply. JAMA Intern Med. 2024;184:449-450. PMID 38372969 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Islam SMS, et al. Wearable cuffless blood pressure monitoring devices: a systematic review and meta-analysis. Eur Heart J Digit Health. 2022;3:323-337. PMID 36713001 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Kollias A, et al. Prognostic value of home versus ambulatory blood pressure monitoring: a systematic review and meta-analysis of outcome studies. J Hypertens. 2024;42:385-392. PMID 38164947 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md
• Kottke TE, et al. Association of an Automated Blood Pressure Measurement Quality Improvement Program With Terminal Digit Preference and Recorded Mean Blood Pressure in 11 Clinics. JAMA Netw Open. 2022;5:e2229098. PMID 36044216 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Kyriakoulis KG, et al. Atrial Fibrillation Screening During Routine Automated Office, Home, and Ambulatory Blood Pressure Measurement: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis. Hypertension. 2024;81:1477-1488. PMID 38602099 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Liang NP, et al. Aldosterone and Impaired Nocturnal Blood Pressure Decline in Primary Aldosteronism. J Am Heart Assoc. 2026;15:e044976. PMID 41804894 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Lucinde RK, et al. Diagnostic Performance of Unattended Automated Office Blood Pressure Measurement for Hypertension Screening Among People With and Without HIV. J Am Heart Assoc. 2025;14:e043957. PMID 40970526 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/special-populations.md
• McManus RJ, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376:163-72. PMID 20619448 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md, wiki/definition-measurement-and-diagnosis.md
• McManus RJ, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391:949-959. PMID 29499873 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md, wiki/definition-measurement-and-diagnosis.md
• Mortazavi BJ, et al. Classification of blood pressure during sleep impacts designation of nocturnal nondipping. PLOS Digit Health. 2023;2:e0000267. PMID 37310958 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Nietert PJ, et al. Effect of terminal digit preference on blood pressure measurement and treatment in primary care. Am J Hypertens. 2006;19:147-52. PMID 16448884 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Oguaju B, et al. Inter-observer reliability and anatomical landmarks for arm circumference to determine cuff size for blood pressure measurement. J Clin Hypertens (Greenwich). 2024;26:867-871. PMID 38980266 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Palatini P. Pitfalls of Cuff Size and Blood Pressure Measurement. JAMA Intern Med. 2024;184:447-448. PMID 38372995 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Palatini P. Challenges and pitfalls of cuff oscillometric blood pressure measurement. Hypertens Res. 2025;48:1993-1996. PMID 40199977 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Palatini P, et al. Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens. 2018;36:1222-1236. PMID 29570514 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/definition-measurement-and-diagnosis.md, wiki/special-populations.md
• Palatini P, et al. Association of Extreme Nocturnal Dipping With Cardiovascular Events Strongly Depends on Age. Hypertension. 2020;75:324-330. PMID 31865788 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Palla M, et al. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Press Control. 2018;11:11-24. PMID 29379316 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Parati G, et al. Nocturnal blood pressure: pathophysiology, measurement and clinical implications. Position paper of the European Society of Hypertension. J Hypertens. 2025;43:1296-1318. PMID 40509714 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, literature/patient-voice/organizations.md, wiki/definition-measurement-and-diagnosis.md
• Park CH, et al. Nocturnal systolic blood pressure dipping and progression of chronic kidney disease. Hypertens Res. 2024;47:215-224. PMID 37452154 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/special-populations.md
• Picone DS, et al. Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: Major Implications for Cardiovascular Risk Management. Hypertension. 2020;75:1593-1599. PMID 32275193 — tags: [hypertension, primary] — cited by: literature/patient-voice/organizations.md, literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Pierdomenico SD, et al. Prognostic Value of Masked Uncontrolled Hypertension. Hypertension. 2018;72:862-869. PMID 30354717 — tags: [hypertension, meta-analysis] — cited by: wiki/definition-measurement-and-diagnosis.md
• Pilz N, et al. Cuff-based blood pressure measurement: challenges and solutions. Blood Press. 2024;33:2402368. PMID 39291896 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Ruzicka M, et al. How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional Study. PLoS One. 2016;11:e0155677. PMID 27249056 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Saladini F, et al. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens. 2011;29:1311-9. PMID 21659824 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Saladini F, et al. Isolated Systolic Hypertension in Young Individuals: Pathophysiological Mechanisms, Prognostic Significance, and Clinical Implications. High Blood Press Cardiovasc Prev. 2017;24:133-139. PMID 28374153 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Salvetti M, et al. Unattended Versus Attended Blood Pressure Measurement. Hypertension. 2019;73:736-742. PMID 30686088 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/blood-pressure-targets.md, wiki/definition-measurement-and-diagnosis.md
• Schutte AE. Wearable cuffless blood pressure tracking: when will they be good enough?. J Hum Hypertens. 2024;38:669-672. PMID 38997475 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Shahi S, et al. Cuff Size Variation Across Manufacturers of Home Blood Pressure Devices: A Current Patient Dilemma. Am J Hypertens. 2023;36:532-535. PMID 37422909 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Siddiqui M, et al. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence. Hypertension. 2019;74:652-659. PMID 31327263 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/resistant-and-refractory-hypertension.md
• Staplin N, et al. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients. Lancet. 2023;401:2041-2050. PMID 37156250 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md, wiki/risk-and-outcomes.md
• Stergiou GS, et al. Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis. J Hypertens. 2012;30:2074-82. PMID 22914573 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/definition-measurement-and-diagnosis.md, wiki/red-flags-and-safety-concerns.md
• Sánchez Bacaicoa M, et al. Automated Office Blood Pressure Measurements in Waiting Room or Isolated Room for Diagnosis and Phenotyping of Hypertension. J Am Heart Assoc. 2025;14:e038011. PMID 41085208 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Tang A, et al. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?. Curr Hypertens Rep. 2024;26:21-30. PMID 37955827 — tags: [hypertension, review] — cited by: wiki/definition-measurement-and-diagnosis.md
• Tucker KL, et al. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med. 2017;14:e1002389. PMID 28926573 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/patient-voice/sources.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/definition-measurement-and-diagnosis.md, wiki/hypertension-in-pregnancy.md, wiki/patient-experience-and-advocacy.md
• Wingfield D, et al. Selective recording in blood pressure readings may increase subsequent mortality. QJM. 2002;95:571-7. PMID 12205334 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md
• Yang WY, et al. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes. JAMA. 2019;322:409-420. PMID 31386134 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md
• Zhang DY, et al. Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis. Eur Heart J. 2025;46:2974-2987. PMID 40249369 — tags: [hypertension, meta-analysis] — cited by: literature/statistics/STATISTICS.md, wiki/definition-measurement-and-diagnosis.md
• Zhu H, et al. Prevalence and Cardio-Renal Comorbidities of Masked Hypertension: A Meta-Analysis. J Evid Based Med. 2024;17:833-842. PMID 39722158 — tags: [hypertension, meta-analysis] — cited by: wiki/definition-measurement-and-diagnosis.md
• Zuin M, et al. Pitfalls of Cuff Size and Blood Pressure Measurement. JAMA Intern Med. 2024;184:448. PMID 38372978 — tags: [hypertension, primary] — cited by: wiki/definition-measurement-and-diagnosis.md

Risk, dose-response and outcomes

• Alderman MH. Blood pressure J-curve: is it cause or effect?. Curr Opin Nephrol Hypertens. 1996;5:209-13. PMID 8737854 — tags: [hypertension, review] — cited by: wiki/risk-and-outcomes.md
• Bowling CB, et al. Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults. J Am Geriatr Soc. 2020;68:2059-2066. PMID 32501546 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• de Havenon A, et al. Increased Blood Pressure Variability and the Risk of Probable Dementia or Mild Cognitive Impairment: A Post Hoc Analysis of the SPRINT MIND Trial. J Am Heart Assoc. 2021;10:e022206. PMID 34533059 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Emdin CA, et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 2015;351:h4865. PMID 26419648 — tags: [hypertension, meta-analysis] — cited by: literature/statistics/STATISTICS.md, wiki/risk-and-outcomes.md
• Emdin CA, et al. Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults. Int J Epidemiol. 2017;46:162-172. PMID 27143136 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/risk-and-outcomes.md
• Filippone EJ, et al. The diastolic blood pressure J-curve revisited: An update. Am Heart J Plus. 2021;12:100065. PMID 38559601 — tags: [hypertension, review] — cited by: wiki/risk-and-outcomes.md
• Fuchs FD, et al. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;75:285-292. PMID 31865786 — tags: [hypertension, review] — cited by: wiki/risk-and-outcomes.md
• Hata J, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation. 2013;128:1325-34. PMID 23926207 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• Jiang C, et al. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial. Hypertension. 2023;80:580-589. PMID 36688305 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• Kai H, et al. Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1. Hypertens Res. 2020;43:715-723. PMID 32015482 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Kim BS, et al. Association of office blood pressure with ischemic and bleeding events in patients undergoing percutaneous coronary intervention. Sci Rep. 2024;14:20310. PMID 39218965 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Lee CJ, et al. Prognosis of apparent treatment-resistant hypertension and poor adherence: a nationwide cohort study. Hypertens Res. 2025;48:49-59. PMID 39543414 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md, wiki/risk-and-outcomes.md
• McEvoy JW, et al. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016;68:1713-1722. PMID 27590090 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/red-flags-and-safety-concerns.md, wiki/risk-and-outcomes.md
• Mehlum MH, et al. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. Eur Heart J. 2018;39:2243-2251. PMID 29365085 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Mehlum MH, et al. Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers. Hypertension. 2020;75:1584-1592. PMID 32336236 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, wiki/risk-and-outcomes.md
• Messerli FH, et al. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?. J Am Coll Cardiol. 2009;54:1827-34. PMID 19892233 — tags: [hypertension, review] — cited by: wiki/risk-and-outcomes.md
• Muntner P, et al. Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich). 2014;16:323-30. PMID 24739073 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• Nazarzadeh M, et al. Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study. JAMA Cardiol. 2019;4:788-795. PMID 31290937 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/risk-and-outcomes.md
• Ohkuma T, et al. Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study. Hypertension. 2017;70:461-468. PMID 28584014 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• Rahman F, et al. The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates. Curr Atheroscler Rep. 2017;19:34. PMID 28612327 — tags: [hypertension, review] — cited by: wiki/risk-and-outcomes.md
• Rothwell PM, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905. PMID 20226988 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/risk-and-outcomes.md
• Sible IJ, et al. Blood Pressure Variability and Cognitive Decline: A Post Hoc Analysis of the SPRINT MIND Trial. Am J Hypertens. 2023;36:168-175. PMID 36448621 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Surendran P, et al. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. Nat Genet. 2020;52:1314-1332. PMID 33230300 — tags: [hypertension, meta-analysis] — cited by: literature/statistics/STATISTICS.md, wiki/genetics-and-monogenic-forms.md, wiki/risk-and-outcomes.md
• Topel ML, et al. Mechanisms underlying the J-curve for diastolic blood pressure: Subclinical myocardial injury and immune activation. Int J Cardiol. 2019;276:255-260. PMID 30217423 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Wang Y, et al. Associations of Long-Term Visit-to-Visit Blood Pressure Variability With Subclinical Kidney Damage and Albuminuria in Adulthood: a 30-Year Prospective Cohort Study. Hypertension. 2022;79:1247-1256. PMID 35360932 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Webb AJ, et al. Blood pressure variability and risk of new-onset atrial fibrillation: a systematic review of randomized trials of antihypertensive drugs. Stroke. 2010;41:2091-3. PMID 20651263 — tags: [hypertension, systematic-review, review] — cited by: wiki/risk-and-outcomes.md
• Webb AJ, et al. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke. 2011;42:2860-5. PMID 21817143 — tags: [hypertension, systematic-review, review] — cited by: OPEN-QUESTIONS.md, wiki/risk-and-outcomes.md
• Webb AJS, et al. Prognostic Significance of Blood Pressure Variability on Beat-to-Beat Monitoring After Transient Ischemic Attack and Stroke. Stroke. 2018;49:62-67. PMID 29229726 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Yadav S, et al. Genome-wide analysis of blood pressure variability and ischemic stroke. Stroke. 2013;44:2703-2709. PMID 23929743 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Yang R, et al. Diastolic Blood Pressure and Cognitive Function in Adults With Achieved Systolic Blood Pressure Below 130 mm Hg: Insights From the SPRINT-MIND Trial. Circ Cardiovasc Qual Outcomes. 2025;18:e011902. PMID 41070444 — tags: [hypertension, rct] — cited by: wiki/risk-and-outcomes.md
• Yu J, et al. Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial. Hypertension. 2023;80:1507-1516. PMID 37170806 — tags: [hypertension, primary] — cited by: wiki/risk-and-outcomes.md
• Zhang Y, et al. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events. J Am Coll Cardiol. 2019;74:330-341. PMID 31319915 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/risk-and-outcomes.md

Pathophysiology and mechanism

• Alexander MR, et al. A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage. Circ Res. 2022;131:731-747. PMID 36169218 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/genetics-and-monogenic-forms.md, wiki/pathophysiology.md
• Ames MK, et al. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33:363-382. PMID 30806496 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Andersson C, et al. Association of Parental Hypertension With Arterial Stiffness in Nonhypertensive Offspring: The Framingham Heart Study. Hypertension. 2016;68:584-9. PMID 27456526 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Bartolomaeus H, et al. Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage. Circulation. 2019;139:1407-1421. PMID 30586752 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Beard DA, et al. A computational analysis of the long-term regulation of arterial pressure. F1000Res. 2013;2:208. PMID 24555102 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pathophysiology.md
• Brands MW. Chronic blood pressure control. Compr Physiol. 2012;2:2481-94. PMID 23720255 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Butler HM, et al. Salt-sensitive hypertension: role of endothelial and vascular dysfunction and sex. Front Pharmacol. 2025;16:1565962. PMID 40144661 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Catena C, et al. Aldosterone, organ damage and dietary salt. Clin Exp Pharmacol Physiol. 2013;40:922-8. PMID 23803228 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Cohen JB, et al. Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank. Circ Res. 2022;131:545-554. PMID 35946401 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Dahlmann A, et al. Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients. Kidney Int. 2015;87:434-41. PMID 25100048 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pathophysiology.md
• Davies M, et al. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK. Am J Physiol Renal Physiol. 2014;307:F96-F106. PMID 24808538 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• de Oliveira MG, et al. Endothelial and vascular smooth muscle dysfunction in hypertension. Biochem Pharmacol. 2022;205:115263. PMID 36174768 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Durante A, et al. Systemic and Cardiac Microvascular Dysfunction in Hypertension. Int J Mol Sci. 2024;25. PMID 39769057 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Esler M, et al. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1-7. PMID 11346214 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Gan L, et al. Immune cells and hypertension. Immunol Res. 2024;72:1-13. PMID 38044398 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Gomez-Sanchez EP. Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens. 2004;13:191-6. PMID 15202613 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Hall JE, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116:991-1006. PMID 25767285 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Heusser K, et al. Baroreflex failure. Hypertension. 2005;45:834-9. PMID 15837841 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Hill MA, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. PMID 33766485 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Hofmeister LH, et al. Tissue sodium storage: evidence for kidney-like extrarenal countercurrent systems?. Pflugers Arch. 2015;467:551-8. PMID 25600900 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Hu W, et al. Regulatory T cells and cardiovascular diseases. Chin Med J (Engl). 2023;136:2812-2823. PMID 37840195 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Iatrino R, et al. Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension. Curr Hypertens Rep. 2016;18:70. PMID 27614755 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Ishizawa K, et al. Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling. Proc Natl Acad Sci U S A. 2019;116:3155-3160. PMID 30718414 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Kahle KT, et al. WNK protein kinases modulate cellular Cl- flux by altering the phosphorylation state of the Na-K-Cl and K-Cl cotransporters. Physiology (Bethesda). 2006;21:326-35. PMID 16990453 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Kobetic MD, et al. Sympathetic-transduction in untreated hypertension. J Hum Hypertens. 2022;36:24-31. PMID 34453103 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Kopp C, et al. 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension. 2013;61:635-40. PMID 23339169 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pathophysiology.md
• Kotsis V, et al. Mechanisms of obesity-induced hypertension. Hypertens Res. 2010;33:386-93. PMID 20442753 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Lother A, et al. Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure. Hypertension. 2016;67:130-8. PMID 26553231 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Luzardo L, et al. Mechanisms of Salt-Sensitive Hypertension. Curr Hypertens Rev. 2015;11:14-21. PMID 26028243 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Mancia G, et al. The sympathetic nervous system in human hypertension. Acta Physiol Scand Suppl. 1997;640:117-21. PMID 9401621 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Meng X, et al. Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol. 2016;13:167-79. PMID 26525543 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Mishra S, et al. Salt sensitivity and its implication in clinical practice. Indian Heart J. 2018;70:556-564. PMID 30170653 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Monette MY, et al. Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport function. Am J Physiol Renal Physiol. 2011;300:F840-7. PMID 21209010 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/pathophysiology.md
• Montani JP, et al. Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure. Exp Physiol. 2009;94:382-8. PMID 19286638 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Nesterov V, et al. In Liddle Syndrome, Epithelial Sodium Channel Is Hyperactive Mainly in the Early Part of the Aldosterone-Sensitive Distal Nephron. Hypertension. 2016;67:1256-62. PMID 27170740 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/pathophysiology.md
• Niiranen TJ, et al. Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study. J Am Heart Assoc. 2016;5. PMID 27912210 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Nishimoto M, et al. Salt-Sensitive Hypertension and the Kidney. Hypertension. 2024;81:1206-1217. PMID 38545804 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• O'Donnell JA, et al. The gut microbiome and hypertension. Nat Rev Nephrol. 2023;19:153-167. PMID 36631562 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• O'Shaughnessy KM. Gordon Syndrome: a continuing story. Pediatr Nephrol. 2015;30:1903-8. PMID 25503323 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/pathophysiology.md
• Osborn JW, et al. Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure. Exp Physiol. 2009;94:389-96. PMID 19286640 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pathophysiology.md
• Ott C, et al. Impact of renal denervation on tissue Na(+) content in treatment-resistant hypertension. Clin Res Cardiol. 2018;107:42-48. PMID 28845508 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/device-and-interventional-therapy.md, wiki/pathophysiology.md
• Parvanova A, et al. Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms. Clin Kidney J. 2024;17:sfad282. PMID 38186879 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Ponce-Coria J, et al. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci U S A. 2008;105:8458-63. PMID 18550832 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• R Muralitharan R, et al. Gut Microbiota Metabolites Sensed by Host GPR41/43 Protect Against Hypertension. Circ Res. 2025;136:e20-e33. PMID 39840468 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• San-Cristobal P, et al. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci U S A. 2009;106:4384-9. PMID 19240212 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Shibata S, et al. Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation. Proc Natl Acad Sci U S A. 2014;111:15556-61. PMID 25313067 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Te Riet L, et al. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116:960-75. PMID 25767283 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Titze J. Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens. 2014;23:101-5. PMID 24401786 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/pathophysiology.md
• Titze J. A different view on sodium balance. Curr Opin Nephrol Hypertens. 2015;24:14-20. PMID 25470013 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Totoń-Żurańska J, et al. Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation. Clin Sci (Lond). 2024;138:817-850. PMID 38920058 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Varadarajan P, et al. Adaptive Immune System in Hypertension: Implicating the Role of T Cells. Curr Cardiol Rev. 2025. PMID 41121514 — tags: [hypertension, primary] — cited by: wiki/pathophysiology.md
• Verhaar BJH, et al. Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients. 2020;12. PMID 33003455 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Verma S, et al. Aldosterone and aldosterone synthase inhibitors in cardiorenal disease. Am J Physiol Heart Circ Physiol. 2024;326:H670-H688. PMID 38133623 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Weinberger MH. Sodium sensitivity of blood pressure. Curr Opin Nephrol Hypertens. 1993;2:935-9. PMID 7922236 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Wu Y, et al. The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension. Front Microbiol. 2021;12:730809. PMID 34650536 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Zhang MZ, et al. Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens. 2015;24:117-22. PMID 25594544 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md
• Zhang Z, et al. Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets. Front Immunol. 2022;13:1098725. PMID 36703963 — tags: [hypertension, review] — cited by: wiki/pathophysiology.md

Genetics, monogenic forms and pharmacogenomics

• Adachi M, et al. Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review. Endocr J. 2023;70:723-729. PMID 37081692 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• Albarwani S, et al. Heritability of ambulatory and beat-to-beat office blood pressure in large multigenerational Arab pedigrees: the 'Oman Family study'. Twin Res Hum Genet. 2012;15:753-8. PMID 22967944 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Anglani F, et al. Genotype-phenotype correlation in Gordon's syndrome: report of two cases carrying novel heterozygous mutations. J Nephrol. 2022;35:859-862. PMID 34089516 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Armstrong ND, et al. Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response. JAMA Cardiol. 2024;9:1134-1141. PMID 39441603 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, wiki/genetics-and-monogenic-forms.md, wiki/special-populations.md
• Bérard E. [Contribution of monogenic hypertension models to understanding of other hypertensions]. Nephrol Ther. 2008;4:312-9. PMID 18448411 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• Collins KS, et al. Genotype-Guided Hydralazine Therapy. Am J Nephrol. 2020;51:764-776. PMID 32927458 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• de las Fuentes L, et al. The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN. Front Genet. 2013;4:304. PMID 24400021 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Deng K, et al. Association of a CCB-Related Pharmacogenomics-Guided Strategy with Blood Pressure Outcomes and Short-Term Safety in Chinese Patients with Hypertension: A Secondary Exploratory Analysis of Two Randomized Cohorts. Drug Healthc Patient Saf. 2026;18:637282. PMID 42553612 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Eadon MT, et al. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment. Expert Rev Precis Med Drug Dev. 2018;3:33-47. PMID 29888336 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Fan P, et al. Truncated Epithelial Sodium Channel β Subunit Responsible for Liddle Syndrome in a Chinese Family. Kidney Blood Press Res. 2019;44:942-949. PMID 31437854 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Fava C, et al. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2013;61:319-26. PMID 23232644 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Glover M, et al. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia. Clin Exp Pharmacol Physiol. 2013;40:876-84. PMID 23683032 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• Keaton JM, et al. Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. Nat Genet. 2024;56:778-791. PMID 38689001 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/genetics-and-monogenic-forms.md
• Kim NY, et al. Associations Between Polygenic Risk Score for Blood Pressure and Risk of Hypertension in Northeast Asian Individuals. J Am Heart Assoc. 2026;15:e045433. PMID 41467372 — tags: [hypertension, meta-analysis] — cited by: wiki/genetics-and-monogenic-forms.md
• Kozina AA, et al. Liddle syndrome due to a novel mutation in the γ subunit of the epithelial sodium channel (ENaC) in family from Russia: a case report. BMC Nephrol. 2019;20:389. PMID 31655555 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Krieger JE. Polygenic risk score translation across diverse populations. Front Cardiovasc Med. 2026;13:1870807. PMID 42395874 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/genetics-and-monogenic-forms.md, wiki/special-populations.md
• Kupper N, et al. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension. 2005;45:80-5. PMID 15557390 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Kurniansyah N, et al. A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood. Nat Commun. 2022;13:3549. PMID 35729114 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/special-populations.md
• Larsson SC, et al. Risk Factors for Intracerebral Hemorrhage: Genome-Wide Association Study and Mendelian Randomization Analyses. Stroke. 2024;55:1582-1591. PMID 38716647 — tags: [hypertension, meta-analysis] — cited by: wiki/genetics-and-monogenic-forms.md
• Lemmens-Gruber R, et al. The Epithelial Sodium Channel-An Underestimated Drug Target. Int J Mol Sci. 2023;24. PMID 37175488 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• Li C, et al. Genome-Wide Gene-Sodium Interaction Analyses on Blood Pressure: The Genetic Epidemiology Network of Salt-Sensitivity Study. Hypertension. 2016;68:348-55. PMID 27271309 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Li C, et al. Genome-Wide Gene-Potassium Interaction Analyses on Blood Pressure: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity). Circ Cardiovasc Genet. 2017;10. PMID 29212900 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Li D, et al. Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation. Cardiovasc Diabetol. 2025;24:241. PMID 40481456 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Mareš Š, et al. A novel nonsense mutation in the β-subunit of the epithelial sodium channel causing Liddle syndrome. Blood Press. 2021;30:291-299. PMID 34223773 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Peces R, et al. A Spanish Family with Gordon Syndrome Due to a Variant in the Acidic Motif of WNK1. Genes (Basel). 2023;14. PMID 37895227 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Quintanilha JCF, et al. Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab-Induced Hypertension in Cancer Patients (Alliance). Clin Pharmacol Ther. 2022;112:364-371. PMID 35527502 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md, wiki/red-flags-and-safety-concerns.md
• Salfati E, et al. Direct Estimates of the Genomic Contributions to Blood Pressure Heritability within a Population-Based Cohort (ARIC). PLoS One. 2015;10:e0133031. PMID 26162070 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/genetics-and-monogenic-forms.md
• Scholl UI. [Hyperaldosteronism]. Internist (Berl). 2021;62:245-251. PMID 33599784 — tags: [hypertension, review] — cited by: wiki/genetics-and-monogenic-forms.md
• Snieder H, et al. Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension. 2003;41:1196-201. PMID 12719445 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Sun X, et al. Life-Course Associations between Blood Pressure-Related Polygenic Risk Scores and Hypertension in the Bogalusa Heart Study. Genes (Basel). 2022;13. PMID 36011384 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Tremblay J, et al. Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control. Diabetologia. 2021;64:2012-2025. PMID 34226943 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Uehara Y, et al. Genetic analysis of the epithelial sodium channel in Liddle's syndrome. J Hypertens. 1998;16:1131-5. PMID 9794716 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Wang X, et al. A Family with Liddle Syndrome Caused by a Novel Stop-Gain Mutation in the γ Subunit of Epithelial Sodium Channels. Nephron. 2022;146:647-651. PMID 35661050 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Xiao ZL, et al. Personalized antihypertensive treatment guided by pharmacogenomics in China. Cardiovasc Diagn Ther. 2022;12:635-645. PMID 36329971 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md
• Zhang H, et al. Deciphering genetic associations with blood pressure in peripheral blood mononuclear cells through single-cell transcriptomic profiling. Hypertens Res. 2025;48:2969-2978. PMID 40877473 — tags: [hypertension, primary] — cited by: wiki/genetics-and-monogenic-forms.md

Secondary hypertension

• Araujo-Castro M, et al. Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score. J Hypertens. 2022;40:2486-2493. PMID 36018220 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Arnold SV, et al. Quality of life effects of renal artery stenting versus medical therapy for atherosclerotic renal-artery stenosis: results from the randomized CORAL trial. Eur Heart J Qual Care Clin Outcomes. 2025;11:1388-1395. PMID 39402005 — tags: [hypertension, rct] — cited by: wiki/secondary-hypertension.md
• ASTRAL Investigators, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-62. PMID 19907042 — tags: [hypertension, rct] — cited by: wiki/secondary-hypertension.md
• Bratton DJ, et al. CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. JAMA. 2015;314:2280-93. PMID 26624827 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/secondary-hypertension.md
• Buffolo F, et al. Primary aldosteronism in the primary care setting. Curr Opin Endocrinol Diabetes Obes. 2018;25:155-159. PMID 29629943 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Burnier M, et al. Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. Circ Res. 2023;132:1050-1063. PMID 37053276 — tags: [hypertension, review] — cited by: wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md, wiki/secondary-hypertension.md, wiki/special-populations.md
• Cano Megías M, et al. Pheochromocytoma-paraganglioma: Biochemical and genetic diagnosis. Nefrologia. 2016;36:481-488. PMID 27161309 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Cooper CJ, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13-22. PMID 24245566 — tags: [hypertension, rct] — cited by: wiki/secondary-hypertension.md
• Correia AS, et al. Long-term follow-up after aortic coarctation repair: the unsolved issue of exercise-induced hypertension. Rev Port Cardiol. 2013;32:879-83. PMID 24239395 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Dekkers T, et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016;4:739-746. PMID 27325147 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/secondary-hypertension.md
• Eisenhofer G. Screening for pheochromocytomas and paragangliomas. Curr Hypertens Rep. 2012;14:130-7. PMID 22258313 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Ekman N, et al. What We Know about and What Is New in Primary Aldosteronism. Int J Mol Sci. 2024;25. PMID 38255973 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Foy MC, et al. Drug-Induced Hypertension. Endocrinol Metab Clin North Am. 2019;48:859-873. PMID 31655781 — tags: [hypertension, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Funder J. Primary aldosteronism. Trends Cardiovasc Med. 2022;32:228-233. PMID 33775861 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Gornik HL, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24:164-189. PMID 30648921 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/secondary-hypertension.md
• Green D, et al. Patient Selection for Revascularization of Atherosclerotic Renal Artery Stenosis: Comparing the Importance of Stenosis Severity and Clinical Phenotype. Kidney Med. 2026;8:101213. PMID 41623301 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Grillo A, et al. Atherosclerotic renal artery stenosis in the post-CORAL Trial Era. A narrative review. Curr Probl Cardiol. 2026;51:103205. PMID 41167516 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Grossman E, et al. Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med. 2012;125:14-22. PMID 22195528 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Hamrahian SM, et al. Hypertension in Chronic Kidney Disease. Adv Exp Med Biol. 2017;956:307-325. PMID 27873228 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md, wiki/special-populations.md
• He C, et al. Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study. Clin Exp Hypertens. 2024;46:2301571. PMID 38270079 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Herrmann SM, et al. Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant. 2015;30:366-75. PMID 24723543 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Huart J, et al. From Fibromuscular Dysplasia to Arterial Dissection and Back. Am J Hypertens. 2023;36:573-585. PMID 37379454 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Hundemer GL, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51-59. PMID 29129576 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/notes/brown-2020-unrecognized-aldosteronism.md, literature/statistics/STATISTICS.md, wiki/secondary-hypertension.md
• Hundemer GL, et al. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study. Circulation. 2024;149:124-134. PMID 38031887 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/clinical-trials-landscape.md, wiki/secondary-hypertension.md
• Jain A, et al. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management. Pediatr Nephrol. 2020;35:581-594. PMID 30603807 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Jones RB Jr, et al. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas. Curr Cardiol Rep. 2023;25:1451-1460. PMID 37847359 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Jurca SJ, et al. Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects. Curr Hypertens Rep. 2016;18:73. PMID 27671491 — tags: [hypertension, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md, wiki/secondary-hypertension.md
• Kadian-Dodov D, et al. Natural History of Cervical Artery Fibromuscular Dysplasia and Associated Neurovascular Events. Cerebrovasc Dis. 2018;46:33-39. PMID 30064124 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Kline GA, et al. Is It Time to Retire Aldosterone Suppression Testing?. Am J Hypertens. 2026;39:473-481. PMID 40887827 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Ku E, et al. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019;74:120-131. PMID 30898362 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md, wiki/special-populations.md
• Labarca G, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): Systematic review and meta-analysis. Sleep Med Rev. 2021;58:101446. PMID 33607443 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/secondary-hypertension.md
• Lovell AR, et al. Drug-Induced Hypertension: Focus on Mechanisms and Management. Curr Hypertens Rep. 2017;19:39. PMID 28451850 — tags: [hypertension, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Meng Z, et al. Long-Term Mortality for Patients of Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020;11:121. PMID 32210920 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/secondary-hypertension.md
• Miller BS, et al. Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System. World J Surg. 2018;42:453-463. PMID 29134312 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Monticone S, et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017;69:1811-1820. PMID 28385310 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/secondary-hypertension.md
• Monticone S, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41-50. PMID 29129575 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/secondary-hypertension.md
• Pacak K, et al. Pheochromocytoma and paraganglioma. Endocr Pract. 2015;21:406-12. PMID 25716634 — tags: [hypertension, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Pan CT, et al. Atrial Fibrillation in Primary Aldosteronism. Horm Metab Res. 2020;52:357-365. PMID 32289838 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Panzer J, et al. Hypertension after coarctation repair-a systematic review. Transl Pediatr. 2022;11:270-279. PMID 35282025 — tags: [hypertension, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Peng N, et al. Effect of Age on Aldosterone-Renin Ratio in Screening Primary Aldosteronism. J Clin Hypertens (Greenwich). 2025;27:e70014. PMID 40065694 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Pengo MF, et al. Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis. Eur Respir J. 2025;65. PMID 39401854 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/secondary-hypertension.md
• Plouin PF, et al. High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hypertension. 2017;70:652-658. PMID 28716989 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Rossi GP, et al. The cardiovascular consequences of hyperaldosteronism. Ann Endocrinol (Paris). 2021;82:174-178. PMID 32192789 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Salciccioli KB, et al. Coarctation of the Aorta: Modern Paradigms Across the Lifespan. Hypertension. 2023;80:1970-1979. PMID 37476999 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Shang W, et al. Benefits of continuous positive airway pressure on blood pressure in patients with hypertension and obstructive sleep apnea: a meta-analysis. Hypertens Res. 2022;45:1802-1813. PMID 35701490 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/secondary-hypertension.md
• Shiina K. Obstructive sleep apnea -related hypertension: a review of the literature and clinical management strategy. Hypertens Res. 2024;47:3085-3098. PMID 39210083 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Stüfchen I, et al. Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome?. J Clin Endocrinol Metab. 2026;111:e1381-e1387. PMID 41175007 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Sun L, et al. Effect of Continuous Positive Airway Pressure on Blood Pressure in Patients with Resistant Hypertension and Obstructive Sleep Apnea: An Updated Meta-analysis. Curr Hypertens Rep. 2024;26:201-211. PMID 38460066 — tags: [hypertension, meta-analysis, review] — cited by: wiki/secondary-hypertension.md
• Sánchez-de-la-Torre M, et al. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA. 2023;330:1255-1265. PMID 37787793 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/secondary-hypertension.md
• Tanabe A, et al. Recent advances in the management of pheochromocytoma and paraganglioma. Hypertens Res. 2020;43:1141-1151. PMID 32778780 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Toro-Salazar OH, et al. Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol. 2002;89:541-7. PMID 11867038 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Turcu AF, et al. Phase 2a Study of Baxdrostat in Primary Aldosteronism. N Engl J Med. 2025;393:515-518. PMID 40658651 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Tuttle KR, et al. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial. Clin J Am Soc Nephrol. 2016;11:1180-1188. PMID 27225988 — tags: [hypertension, rct] — cited by: wiki/secondary-hypertension.md
• Vorselaars WMCM, et al. Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients. Surgery. 2019;166:61-68. PMID 31053245 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Wang Q, et al. Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin-Angiotensin System Inhibitors. J Clin Hypertens (Greenwich). 2026;28:e70197. PMID 41491647 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md
• Williams TA, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689-699. PMID 28576687 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/secondary-hypertension.md
• Yang J, et al. Diagnosing endocrine hypertension: a practical approach. Nephrology (Carlton). 2017;22:663-677. PMID 28556585 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Ye L, et al. Hypertension in aortic coarctation. Front Cardiovasc Med. 2025;12:1505269. PMID 40260103 — tags: [hypertension, review] — cited by: wiki/secondary-hypertension.md
• Ylinen MK, et al. Predictors of blood pressure and hypertension long-term after treatment of isolated coarctation of the aorta in children-a population-based study. Interact Cardiovasc Thorac Surg. 2022;35. PMID 35944231 — tags: [hypertension, primary] — cited by: wiki/secondary-hypertension.md

Blood-pressure targets and target trials

• Aggarwal R, et al. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients. Hypertension. 2019;73:1275-1282. PMID 31067189 — tags: [hypertension, rct] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Akhtar A, et al. Intensive Versus Standard Blood Pressure Control in Type 2 Diabetes: Cardiovascular and Microvascular Outcomes. High Blood Press Cardiovasc Prev. 2026;33:153-158. PMID 41266861 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Benetos A, et al. Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians. JAMA. 2015;314:170-80. PMID 26172896 — tags: [hypertension, review] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Cheung AK, et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28:2812-2823. PMID 28642330 — tags: [hypertension, rct] — cited by: literature/notes/sprint-2015-intensive-control.md, wiki/blood-pressure-targets.md, wiki/special-populations.md
• Cushman WC, et al. Blood Pressure Intervention and Control in SPRINT. Hypertension. 2022;79:2071-2080. PMID 35766041 — tags: [hypertension, rct] — cited by: literature/notes/sprint-2015-intensive-control.md, wiki/blood-pressure-targets.md
• Falk JM, et al. Higher blood pressure targets for hypertension in older adults. Cochrane Database Syst Rev. 2024;12:CD011575. PMID 39688187 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/clinical-trials-landscape.md, wiki/special-populations.md
• Ioannidou E, et al. Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023;17:102782. PMID 37257222 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Jiao T, et al. Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data. Diabetes Obes Metab. 2024;26:1502-1509. PMID 38297986 — tags: [hypertension, primary] — cited by: wiki/blood-pressure-targets.md
• Liao CT, et al. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension. JAMA Netw Open. 2023;6:e230708. PMID 36848091 — tags: [hypertension, primary] — cited by: wiki/blood-pressure-targets.md
• Nguyen TN, et al. The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial. Diabetes Care. 2021;44:1622-1629. PMID 34035077 — tags: [hypertension, primary] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Rizwanullah U, et al. Impact of Intensive Blood Pressure Control Versus Standard Control on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cureus. 2025;17:e87456. PMID 40772210 — tags: [hypertension, review] — cited by: wiki/blood-pressure-targets.md
• Saad M, et al. Effects of intensive blood pressure control on cardiovascular outcomes in patients with diabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2025;19:422-425. PMID 40769802 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Sheppard JP, et al. The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. PLoS Med. 2023;20:e1004223. PMID 37075078 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/blood-pressure-targets.md, wiki/patient-experience-and-advocacy.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Song Q, et al. Intensive Blood Pressure Control in Older Patients With Hypertension: 6-Year Results of the STEP Trial. J Am Coll Cardiol. 2025;86:1421-1433. PMID 41105077 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/special-populations.md
• SPS3 Study Group, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507-15. PMID 23726159 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/special-populations.md
• Tomson CRV, et al. Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. Ann Intern Med. 2021;174:1270-1281. PMID 34152826 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/blood-pressure-targets.md, wiki/special-populations.md
• Wang Z, et al. Intensive Blood Pressure Control in Patients With Diabetes and Previous Stroke: A Post-Hoc Analysis of ACCORD-BP Trial. J Clin Hypertens (Greenwich). 2025;27:e70095. PMID 40685691 — tags: [hypertension, rct] — cited by: wiki/blood-pressure-targets.md
• Weiss J, et al. Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis. Ann Intern Med. 2017;166:419-429. PMID 28114673 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Wenjie L, et al. The Impact of frailty on the effectiveness of intensive blood pressure control for patients with type 2 diabetes: a secondary analysis of a randomised controlled trial. Heart. 2025;111:626-633. PMID 39915072 — tags: [hypertension, rct] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Xu X, et al. Effects of Intensive Systolic Blood Pressure Control on Kidney Outcomes in Patients With and Without CKD: A Post Hoc Analysis of SPRINT and ACCORD-BP Trials. J Diabetes. 2025;17:e70162. PMID 41117098 — tags: [hypertension, rct] — cited by: wiki/blood-pressure-targets.md, wiki/special-populations.md
• Zhang W, et al. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med. 2021;385:1268-1279. PMID 34491661 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/blood-pressure-targets.md, wiki/special-populations.md

Lifestyle, sodium, potassium and diet

• Ansari HUH, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis. Endocr Pract. 2024;30:160-171. PMID 38029929 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Baffour-Awuah B, et al. Isometric Resistance Training to Manage Hypertension: Systematic Review and Meta-analysis. Curr Hypertens Rep. 2023;25:35-49. PMID 36853479 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Binia A, et al. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015;33:1509-20. PMID 26039623 — tags: [hypertension, meta-analysis, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Borrelli S, et al. Sodium Intake and Chronic Kidney Disease. Int J Mol Sci. 2020;21. PMID 32635265 — tags: [hypertension, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Brand A, et al. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women. Cochrane Database Syst Rev. 2022;8:CD015207. PMID 35944931 — tags: [hypertension, systematic-review, review] — cited by: OPEN-QUESTIONS.md, wiki/lifestyle-and-dietary-management.md, wiki/red-flags-and-safety-concerns.md
• Cappuccio FP, et al. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens. 1991;9:465-73. PMID 1649867 — tags: [hypertension, meta-analysis] — cited by: wiki/lifestyle-and-dietary-management.md
• Carlson DJ, et al. Isometric exercise training for blood pressure management: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89:327-34. PMID 24582191 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Cornelissen VA, et al. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004473. PMID 23525435 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Ding X, et al. Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical Trial. JAMA Cardiol. 2025;10:343-350. PMID 39908026 — tags: [hypertension, rct] — cited by: literature/notes/neal-2021-salt-substitution.md, wiki/lifestyle-and-dietary-management.md
• Elmaleh-Sachs A, et al. Obesity Management in Adults: A Review. JAMA. 2023;330:2000-2015. PMID 38015216 — tags: [hypertension, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Filippini T, et al. The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. Int J Cardiol. 2017;230:127-135. PMID 28024910 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Filippini T, et al. Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2020;9:e015719. PMID 32500831 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Filippou C, et al. Overview of salt restriction in the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean diet for blood pressure reduction. Rev Cardiovasc Med. 2022;23:36. PMID 35092228 — tags: [hypertension, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Filippou C, et al. DASH vs. Mediterranean diet on a salt restriction background in adults with high normal blood pressure or grade 1 hypertension: A randomized controlled trial. Clin Nutr. 2023;42:1807-1816. PMID 37625311 — tags: [hypertension, rct] — cited by: wiki/lifestyle-and-dietary-management.md
• Filippou CD, et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2020;11:1150-1160. PMID 32330233 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Fu J, et al. Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension. J Am Heart Assoc. 2020;9:e016804. PMID 32975166 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md
• Fuchs FD, et al. The Effect of Alcohol on Blood Pressure and Hypertension. Curr Hypertens Rep. 2021;23:42. PMID 34762198 — tags: [hypertension, meta-analysis, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Granal M, et al. Effect of changes in potassium intake on blood pressure: a dose-response meta-analysis of randomized clinical trials (2000-2024). Clin Kidney J. 2025;18:sfaf173. PMID 40612568 — tags: [hypertension, primary] — cited by: wiki/lifestyle-and-dietary-management.md
• Guo R, et al. Effects of the Modified DASH Diet on Adults With Elevated Blood Pressure or Hypertension: A Systematic Review and Meta-Analysis. Front Nutr. 2021;8:725020. PMID 34557511 — tags: [hypertension, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• He FJ, et al. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761-70. PMID 12444537 — tags: [hypertension, meta-analysis] — cited by: wiki/lifestyle-and-dietary-management.md
• He FJ, et al. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;2013:CD004937. PMID 23633321 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Huang L, et al. Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS). Am Heart J. 2020;221:136-145. PMID 31986290 — tags: [hypertension, rct] — cited by: literature/notes/neal-2021-salt-substitution.md, wiki/lifestyle-and-dietary-management.md
• Huang L, et al. The impact of baseline potassium intake on the dose-response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials. J Hum Hypertens. 2021;35:946-957. PMID 33674705 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Kong F, et al. Dietary salt intake and cardiovascular outcomes: an umbrella review of meta-analyses and dose-response evidence. Ann Med. 2025;57:2582065. PMID 41243115 — tags: [hypertension, systematic-review, review] — cited by: OPEN-QUESTIONS.md, wiki/lifestyle-and-dietary-management.md
• Liu X, et al. Associations of estimated 24-h urinary sodium excretion with mortality and cardiovascular events in Chinese adults: a prospective cohort study. J Hypertens. 2021;39:484-493. PMID 33031177 — tags: [hypertension, primary] — cited by: wiki/lifestyle-and-dietary-management.md
• McGowan B, et al. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. Nat Med. 2025;31:3317-3329. PMID 41039116 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• McLaren L, et al. Population-level interventions in government jurisdictions for dietary sodium reduction. Cochrane Database Syst Rev. 2016;9:CD010166. PMID 27633834 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/lifestyle-and-dietary-management.md
• McMahon EJ, et al. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2021;6:CD010070. PMID 34164803 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Mente A, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388:465-75. PMID 27216139 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, wiki/lifestyle-and-dietary-management.md
• Ndumele CE, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87:e1889-e2007. PMID 42265997 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/lifestyle-and-dietary-management.md, wiki/special-populations.md
• O'Donnell M, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612-23. PMID 25119607 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md
• O'Donnell M, et al. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. BMJ. 2019;364:l772. PMID 30867146 — tags: [hypertension, primary] — cited by: wiki/lifestyle-and-dietary-management.md
• Pilla SJ, et al. Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial. JAMA Intern Med. 2025;185:937-946. PMID 40489102 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md, wiki/special-populations.md
• Rees K, et al. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev. 2013;2013:CD002128. PMID 24318424 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Semlitsch T, et al. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev. 2021;2:CD008274. PMID 33555049 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Song J, et al. Impact of color-coded and warning nutrition labelling schemes: A systematic review and network meta-analysis. PLoS Med. 2021;18:e1003765. PMID 34610024 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Theodoridis X, et al. Adherence to the DASH Diet and Risk of Hypertension: A Systematic Review and Meta-Analysis. Nutrients. 2023;15. PMID 37513679 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Tsai YC, et al. Effectiveness of salt substitute on cardiovascular outcomes: A systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2022;24:1147-1160. PMID 36196475 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/lifestyle-and-dietary-management.md
• Wang F, et al. Effect of salt substitution on fracture-a secondary analysis of the Salt Substitute and Stroke Study (SSaSS). BMC Med. 2024;22:366. PMID 39232779 — tags: [hypertension, rct] — cited by: literature/notes/neal-2021-salt-substitution.md, wiki/lifestyle-and-dietary-management.md
• Webster KE, et al. Effectiveness of stress management and relaxation interventions for management of hypertension and prehypertension: systematic review and network meta-analysis. BMJ Med. 2025;4:e001098. PMID 40519356 — tags: [hypertension, primary] — cited by: wiki/lifestyle-and-dietary-management.md
• Whelton PK, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624-32. PMID 9168293 — tags: [hypertension, meta-analysis] — cited by: wiki/lifestyle-and-dietary-management.md
• Xin X, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-7. PMID 11711507 — tags: [hypertension, meta-analysis] — cited by: wiki/lifestyle-and-dietary-management.md
• Yin X, et al. Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart. 2022;108:1608-1615. PMID 35945000 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/notes/neal-2021-salt-substitution.md, literature/statistics/STATISTICS.md, wiki/lifestyle-and-dietary-management.md
• Yin Y, et al. Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled Trials. J Diabetes. 2025;17:e70082. PMID 40207414 — tags: [hypertension, meta-analysis] — cited by: wiki/lifestyle-and-dietary-management.md
• Yu J, et al. Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes. Hypertension. 2024;81:1031-1040. PMID 38465623 — tags: [hypertension, rct] — cited by: literature/notes/neal-2021-salt-substitution.md, wiki/lifestyle-and-dietary-management.md
• Zhang X, et al. Effect of sodium-reduced potassium-enriched salt substitutes on stomach cancer: the Salt Substitute and Stroke Study (SSaSS). BMC Med. 2025;23:236. PMID 40264179 — tags: [hypertension, rct] — cited by: literature/notes/neal-2021-salt-substitution.md, wiki/lifestyle-and-dietary-management.md

Pharmacological therapy

• Expression of Concern relating to: 'Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: Hygia Chronotherapy Trial'. Eur Heart J. 2020;41:1600. PMID 32318736 — tags: [hypertension, expression-of-concern] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md
• Abuelazm M, et al. The Safety and Efficacy of Quadruple Ultra-Low-Dose Combination (Quadpill) for Hypertension Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Drug Investig. 2023;43:813-826. PMID 37902939 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Ahn JC, et al. Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCT. Hypertension. 2026;83:e25810. PMID 41717679 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Albasri A, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372:n189. PMID 33568342 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md, wiki/red-flags-and-safety-concerns.md
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97. PMID 12479763 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Anand ST, et al. Per-Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention-Diuretic Comparison Project. J Am Heart Assoc. 2026;15:e046142. PMID 41614323 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Azizi M, et al. Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2026;407:988-999. PMID 41794437 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Bakris GL, et al. RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024;331:740-749. PMID 38363577 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md
• Black HR, et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2008;31:353-60. PMID 18000186 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md, wiki/red-flags-and-safety-concerns.md
• Blair HA. Baxdrostat: First Approval. Drugs. 2026. PMID 42625106 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Bradley HA, et al. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens. 2006;24:2131-41. PMID 17053529 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Chow CK, et al. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet. 2017;389:1035-1042. PMID 28190578 — tags: [hypertension, rct, systematic-review] — cited by: wiki/pharmacological-therapy.md
• Crespo JJ, et al. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials. Chronobiol Int. 2020;37:771-780. PMID 32684071 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Dahlöf B, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003. PMID 11937178 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md
• Desai AS, et al. Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial. JAMA. 2025;334:46-55. PMID 40434761 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md
• Dhalla IA, et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med. 2013;158:447-55. PMID 23552325 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Dhillon S. Aprocitentan: First Approval. Drugs. 2024;84:841-847. PMID 38833193 — tags: [hypertension, review] — cited by: wiki/pharmacological-therapy.md
• Dwyer JP, et al. Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial. J Am Soc Nephrol. 2026;37:299-311. PMID 40913594 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md
• Elgendy MS, et al. The efficacy and safety of low-dose triple combination for hypertension treatment: a systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:7721-7736. PMID 39912900 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Fernández JR, et al. Chronotherapy of hypertension: advantages of 48-h ambulatory blood pressure monitoring assessments in MAPEC and Hygia Chronotherapy Trial. Chronobiol Int. 2020;37:739-750. PMID 32684004 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Flack JM, et al. Aprocitentan for Blood Pressure Reduction in Black Patients. Hypertension. 2025;82:601-610. PMID 39840441 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Gnanenthiran SR, et al. Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial. JAMA Cardiol. 2022;7:645-650. PMID 35416909 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Hermida RC, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020;41:4565-4576. PMID 31641769 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md
• Hermida RC, et al. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as documented by MAPEC and Hygia Chronotherapy outcomes trials. Chronobiol Int. 2020;37:731-738. PMID 32684008 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Huffman MD, et al. Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial. Hypertens Res. 2024;47:1668-1677. PMID 38584159 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Ishani A, et al. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. N Engl J Med. 2022;387:2401-2410. PMID 36516076 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md, wiki/red-flags-and-safety-concerns.md
• Ishani A, et al. Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7:e2449576. PMID 39656458 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Ishani A, et al. Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7:e2411081. PMID 38743423 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Jadhav U, et al. Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT study. PLoS One. 2014;9:e92955. PMID 24714044 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Jamerson K, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-28. PMID 19052124 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md
• Julius S, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-31. PMID 15207952 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Kim HJ, et al. Single-Pill Combination Olmesartan/Amlodipine/Hydrochlorothiazide Safety and Effectiveness in Older Patients with Hypertension: Pooled Analysis of Post-Approval Observational Studies. Adv Ther. 2026;43:2593-2610. PMID 41915114 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Kjeldsen SE, et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA. 2002;288:1491-8. PMID 12243636 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Kovoor JG, et al. Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial. J Hum Hypertens. 2024;38:516-522. PMID 38744907 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md, wiki/pharmacological-therapy.md
• Laffin LJ, et al. Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial. JAMA. 2023;330:1140-1150. PMID 37690061 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Laffin LJ, et al. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension. N Engl J Med. 2025;392:1813-1823. PMID 40267417 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Lim S, et al. Comparison of Cardiovascular Outcomes Between Chlorthalidone and Hydrochlorothiazide in Hypertensive Patients. J Clin Hypertens (Greenwich). 2025;27:e70000. PMID 39957722 — tags: [hypertension, primary] — cited by: wiki/pharmacological-therapy.md
• Mackenzie IS, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400:1417-1425. PMID 36240838 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/pharmacological-therapy.md
• Mancia G, et al. Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens. 2015;33:401-11. PMID 25380149 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Manolis AA, et al. Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?. Curr Hypertens Rep. 2019;21:22. PMID 30826898 — tags: [hypertension, review] — cited by: wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Marschner S, et al. Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension. Open Heart. 2025;12. PMID 41419232 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Nolde JM, et al. Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication. J Hypertens. 2024;42:1009-1018. PMID 38501351 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Okin PM, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation. 2003;108:684-90. PMID 12885747 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• ONTARGET Investigators, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-59. PMID 18378520 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md, wiki/red-flags-and-safety-concerns.md
• Reinhart M, et al. First-line diuretics versus other classes of antihypertensive drugs for hypertension. Cochrane Database Syst Rev. 2023;7:CD008161. PMID 37439548 — tags: [hypertension, review] — cited by: wiki/pharmacological-therapy.md
• Rossignol P, et al. Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension. Hypertension. 2026;83:e25563. PMID 41363010 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Roush GC, et al. Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses. Hypertension. 2012;59:1110-7. PMID 22526259 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Roush GC, et al. Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects. Hypertension. 2015;65:1041-6. PMID 25733245 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Roush GC, et al. Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects. J Hypertens. 2021;39:1254-1260. PMID 33470735 — tags: [hypertension, meta-analysis, systematic-review] — cited by: wiki/pharmacological-therapy.md
• Saxena M, et al. Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial. JAMA. 2025;334:409-418. PMID 40587141 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Song XN, et al. Efficacy and Safety of Chlortalidone and Hydrochlorothiazide in Prevention of Cardiovascular Diseases. Rev Cardiovasc Med. 2024;25:380. PMID 39484134 — tags: [hypertension, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Sulaica EM, et al. A Review of Hypertension Management in Black Male Patients. Mayo Clin Proc. 2020;95:1955-1963. PMID 32276785 — tags: [hypertension, review] — cited by: wiki/pharmacological-therapy.md, wiki/special-populations.md
• Wang N, et al. Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. JAMA Cardiol. 2020;5:1219-1226. PMID 32717045 — tags: [hypertension, rct] — cited by: wiki/pharmacological-therapy.md
• Williams B, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6:464-475. PMID 29655877 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pharmacological-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Wright JT Jr, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595-608. PMID 15811979 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/pharmacological-therapy.md, wiki/special-populations.md
• Wu HY, et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. BMJ. 2013;347:f6008. PMID 24157497 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md, wiki/special-populations.md
• Yi X, et al. Renin-Angiotensin-Aldosterone System Modulators in Adults with Hypertension: A Network Meta-Analysis of Randomized Controlled Trials. Drugs. 2024;84:1445-1462. PMID 39312177 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/pharmacological-therapy.md
• Zhu J, et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev. 2022;1:CD003654. PMID 35000192 — tags: [hypertension, systematic-review, review] — cited by: wiki/pharmacological-therapy.md

Resistant and refractory hypertension

• Azizi M, et al. Diagnosis and Management of Resistant Hypertension: A Review. JAMA. 2026;335:1428-1439. PMID 41870448 — tags: [hypertension, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/clinical-trials-landscape.md, wiki/device-and-interventional-therapy.md, wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md
• Bangalore S, et al. Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. Am J Med. 2017;130:439-448.e9. PMID 27984005 — tags: [hypertension, rct] — cited by: wiki/resistant-and-refractory-hypertension.md
• Camafort M, et al. Diagnosis and management of resistant hypertension. Heart. 2024;110:1336-1342. PMID 38135468 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Chernova I, et al. Resistant Hypertension Updated Guidelines. Curr Cardiol Rep. 2019;21:117. PMID 31471727 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• de la Sierra A. Profile of ambulatory blood pressure in resistant hypertension. Hypertens Res. 2013;36:565-9. PMID 23595047 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Dong X, et al. Effect of intensive blood pressure control in patients with resistant hypertension: insights from the STEP trial. Eur J Prev Cardiol. 2026;33:1218-1226. PMID 40796327 — tags: [hypertension, rct] — cited by: wiki/resistant-and-refractory-hypertension.md
• Durand H, et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J Hypertens. 2017;35:2346-2357. PMID 28777133 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/red-flags-and-safety-concerns.md, wiki/resistant-and-refractory-hypertension.md
• Fadl Elmula FEM, et al. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis. Blood Press. 2017;26:195-203. PMID 28443356 — tags: [hypertension, meta-analysis] — cited by: wiki/device-and-interventional-therapy.md, wiki/resistant-and-refractory-hypertension.md
• Filippone EJ, et al. Controversies in Hypertension V: Resistant and Refractory Hypertension. Am J Med. 2024;137:12-22. PMID 37832756 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Georges CMG, et al. Drug adherence and psychological factors in patients with apparently treatment-resistant hypertension: Yes but which ones?. J Clin Hypertens (Greenwich). 2022;24:1436-1443. PMID 36225118 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Georgianos PI, et al. Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management. J Am Soc Nephrol. 2024;35:505-514. PMID 38227447 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md, wiki/special-populations.md
• Gupta P, et al. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence. Hypertension. 2017;70:1042-1048. PMID 28847892 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/adherence-and-implementation.md, wiki/resistant-and-refractory-hypertension.md
• Hamdidouche I, et al. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017;35:1891-1898. PMID 28505066 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md, wiki/resistant-and-refractory-hypertension.md
• Highton PJ, et al. Chemical Adherence Testing for Assessing Adherence to Antihypertensive Medications: A Systematic Review and Meta-Analysis of Prevalence of Nonadherence. Behav Med. 2025;51:265-279. PMID 40371625 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/patient-voice/sources.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md, wiki/resistant-and-refractory-hypertension.md
• Kim HM, et al. Role of home blood pressure monitoring in resistant hypertension. Clin Hypertens. 2023;29:2. PMID 36641498 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Lazaridis AA, et al. Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?. Curr Hypertens Rep. 2015;17:78. PMID 26277726 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Modolo R, et al. The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension. Blood Press. 2014;23:276-80. PMID 24571101 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Modolo R, et al. Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic. J Am Soc Hypertens. 2015;9:397-402. PMID 25979412 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Moreno H. Pseudo and resistant hypertension: A chaotic perspective. J Clin Hypertens (Greenwich). 2022;24:698-703. PMID 35466494 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Nardoianni G, et al. Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach. High Blood Press Cardiovasc Prev. 2024;31:99-112. PMID 38616212 — tags: [hypertension, systematic-review, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Naseralallah L, et al. Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension. Blood Press. 2024;33:2424824. PMID 39520722 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Nguyen T, et al. Aprocitentan: The First Endothelin Receptor Antagonist for Resistant Hypertension. Am J Ther. 2025;32:e536-e541. PMID 40638911 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Noubiap JJ, et al. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2019;105:98-105. PMID 30087099 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/resistant-and-refractory-hypertension.md, wiki/special-populations.md
• Petit G, et al. Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension. Blood Press. 2018;27:358-367. PMID 29952236 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Schiffrin EL, et al. Diagnosis and management of resistant hypertension. BMJ. 2024;385:e079108. PMID 38897628 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Schlaich MP, et al. Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension. J Hypertens. 2026;44:180-188. PMID 41195725 — tags: [hypertension, rct] — cited by: wiki/resistant-and-refractory-hypertension.md
• Wei FF, et al. Resistant hypertension. Kardiol Pol. 2018;76:1031-1042. PMID 29905926 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md
• Yun F, et al. Intermittent fasting ameliorates resistant hypertension through modulation of gut microbiota. Pharmacol Res. 2025;219:107864. PMID 40701347 — tags: [hypertension, primary] — cited by: wiki/resistant-and-refractory-hypertension.md
• Zoccali C, et al. New trials in resistant hypertension: mixed blessing stories. Clin Kidney J. 2024;17:sfad251. PMID 38186891 — tags: [hypertension, review] — cited by: wiki/resistant-and-refractory-hypertension.md

Devices and interventional therapy

• Azizi M, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391:2335-2345. PMID 29803590 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Azizi M, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397:2476-2486. PMID 34010611 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Azizi M, et al. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial. JAMA Cardiol. 2022;7:1244-1252. PMID 36350593 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Azizi M, et al. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Circulation. 2024;149:747-759. PMID 37883784 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md
• Bakris GL, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64:1071-8. PMID 24858423 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Bakris GL, et al. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015;65:1314-1321. PMID 25835443 — tags: [hypertension, rct] — cited by: literature/notes/bhatt-2014-symplicity-htn3.md, wiki/device-and-interventional-therapy.md
• Bhatt DL, et al. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet. 2022;400:1405-1416. PMID 36130612 — tags: [hypertension, rct] — cited by: literature/notes/bhatt-2014-symplicity-htn3.md, literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md
• Bisognano JD, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58:765-73. PMID 21816315 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md
• Bloch MJ, et al. 36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIO. Hypertens Res. 2024;47:3467-3472. PMID 39333663 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Brier TJ, et al. Central arteriovenous anastomosis for hypertension: it is not all about sympathomodulation. Future Cardiol. 2015;11:503-6. PMID 26403331 — tags: [hypertension, primary] — cited by: wiki/device-and-interventional-therapy.md
• Böhm M, et al. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. Eur Heart J. 2019;40:743-751. PMID 30608521 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Epstein M, et al. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?. J Am Soc Hypertens. 2015;9:140-9. PMID 25649995 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Fisher NDL, et al. Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial. J Hypertens. 2022;40:221-228. PMID 34433763 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Flack JM, et al. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. J Am Soc Hypertens. 2015;9:769-779. PMID 26362830 — tags: [hypertension, rct] — cited by: literature/notes/bhatt-2014-symplicity-htn3.md, wiki/device-and-interventional-therapy.md
• Gierthmuehlen M, et al. Implant-Mediated Therapy of Arterial Hypertension. Curr Hypertens Rep. 2020;22:16. PMID 32030509 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Iturriaga R. Carotid Body Ablation: a New Target to Address Central Autonomic Dysfunction. Curr Hypertens Rep. 2018;20:53. PMID 29789952 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Iturriaga R. Translating carotid body function into clinical medicine. J Physiol. 2018;596:3067-3077. PMID 29114876 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Kandzari DE, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015;36:219-27. PMID 25400162 — tags: [hypertension, rct] — cited by: literature/notes/bhatt-2014-symplicity-htn3.md, wiki/device-and-interventional-therapy.md
• Kandzari DE, et al. Long-term clinical benefit after radiofrequency renal denervation: pooled 36-month results from the SPYRAL Clinical Program. EuroIntervention. 2026;22:585-593. PMID 42137915 — tags: [hypertension, primary] — cited by: wiki/device-and-interventional-therapy.md
• Kapil V, et al. Central arteriovenous anastomosis to treat resistant hypertension. Curr Opin Nephrol Hypertens. 2018;27:8-15. PMID 29084002 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Kario K, et al. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension　- Insights From the SYMPLICITY HTN-3 Trial. Circ J. 2016;80:1404-12. PMID 27118620 — tags: [hypertension, rct] — cited by: literature/notes/bhatt-2014-symplicity-htn3.md, wiki/device-and-interventional-therapy.md
• Kario K, et al. Twenty-Four-Hour Ambulatory Blood Pressure Reduction Patterns After Renal Denervation in the SPYRAL HTN-OFF MED Trial. Circulation. 2018;138:1602-1604. PMID 30354518 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Kario K, et al. Two-year nighttime blood pressure changes after radiofrequency renal denervation: pooled results from the SPYRAL HTN trials. Hypertens Res. 2025;48:1951-1962. PMID 40175677 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Lauder L, et al. Renal Denervation: Is It Ready for Prime Time?. Curr Cardiol Rep. 2019;21:80. PMID 31278490 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Lauder L, et al. Device-based therapies for arterial hypertension. Nat Rev Cardiol. 2020;17:614-628. PMID 32286512 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Lobo MD, et al. Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial. Hypertension. 2017;70:1099-1105. PMID 29061728 — tags: [hypertension, rct] — cited by: literature/statistics/STATISTICS.md, wiki/device-and-interventional-therapy.md
• Lohmeier TE, et al. Device-Based Neuromodulation for Resistant Hypertension Therapy. Circ Res. 2019;124:1071-1093. PMID 30920919 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Mahfoud F, et al. Device Therapy of Hypertension. Circ Res. 2021;128:1080-1099. PMID 33793330 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Mahfoud F, et al. Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial. EuroIntervention. 2021;17:e1024-e1032. PMID 34236037 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Ng FL, et al. Device-based Therapy for Hypertension. Curr Hypertens Rep. 2016;18:61. PMID 27370788 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Oliva RV, et al. Sympathetic activation in resistant hypertension: theory and therapy. Semin Nephrol. 2014;34:550-9. PMID 25416664 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Persu A, et al. Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence. Eur Cardiol. 2014;9:110-114. PMID 30310496 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Rader F, et al. Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial. EuroIntervention. 2022;18:e677-e685. PMID 35913759 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Tolu-Akinnawo O, et al. Hypertension and Device-Based Therapies for Resistant Hypertension: An Up-to-Date Review. Cureus. 2024;16:e66304. PMID 39108770 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Townsend RR, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160-2170. PMID 28859944 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• van Kleef MEAM, et al. Endovascular Baroreflex Amplification for Resistant Hypertension. Curr Hypertens Rep. 2018;20:46. PMID 29744599 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Verdecchia P, et al. Catheter-based renal artery denervation: facts and expectations. Eur J Intern Med. 2023;117:66-77. PMID 37544846 — tags: [hypertension, meta-analysis, review] — cited by: wiki/device-and-interventional-therapy.md
• Victor RG. Carotid baroreflex activation therapy for resistant hypertension. Nat Rev Cardiol. 2015;12:451-63. PMID 26149485 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md
• Weber MA, et al. Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial. Clin Res Cardiol. 2022;111:1269-1275. PMID 35852582 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Weber T, et al. Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial. Hypertension. 2022;79:1506-1514. PMID 35582957 — tags: [hypertension, rct] — cited by: wiki/device-and-interventional-therapy.md
• Zhang M, et al. Innovative Device-Based Treatments for Hypertension. Am J Hypertens. 2026;39:844-859. PMID 41344842 — tags: [hypertension, review] — cited by: wiki/device-and-interventional-therapy.md

Hypertension in pregnancy

• Ahmed RJ, et al. The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial). Hypertension. 2016;68:1049-55. PMID 27550914 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Aquino M, et al. Exploring the Use of Telemonitoring for Patients at High Risk for Hypertensive Disorders of Pregnancy in the Antepartum and Postpartum Periods: Scoping Review. JMIR Mhealth Uhealth. 2020;8:e15095. PMID 32301744 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Barrett PM, et al. Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis protocol. BMJ Open. 2019;9:e027180. PMID 31061049 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Boggess K, et al. Relationship Between Third-Trimester Low Maternal Blood Pressure and Small-for-Gestational-Age Birth Weight in Pregnant Individuals With Mild Chronic Hypertension. Obstet Gynecol. 2025;146:405-412. PMID 40638923 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Brohan MP, et al. Hypertensive disorders of pregnancy and long-term risk of maternal stroke-a systematic review and meta-analysis. Am J Obstet Gynecol. 2023;229:248-268. PMID 36990309 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, wiki/hypertension-in-pregnancy.md
• Brown MA, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018;72:24-43. PMID 29899139 — tags: [hypertension, review] — cited by: literature/guidelines/REGISTRY.md, wiki/hypertension-in-pregnancy.md
• Brown MA, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310. PMID 29803330 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, wiki/hypertension-in-pregnancy.md
• Cairns AE, et al. Implementing self-management: a mixed methods study of women's experiences of a postpartum hypertension intervention (SNAP-HT). Trials. 2020;21:508. PMID 32517785 — tags: [hypertension, rct] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/hypertension-in-pregnancy.md, wiki/patient-experience-and-advocacy.md
• Campbell HE, et al. Detection and Control of Pregnancy Hypertension Using Self-Monitoring of Blood Pressure With Automated Telemonitoring: Cost Analyses of the BUMP Randomized Trials. Hypertension. 2024;81:887-896. PMID 38258566 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Chaemsaithong P, et al. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071-S1097.e2. PMID 32682859 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Chappell LC, et al. Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial. JAMA. 2022;327:1666-1678. PMID 35503345 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Dall'Asta A, et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57:698-709. PMID 32484256 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Fishel Bartal M, et al. Emerging concepts since the Chronic Hypertension and Pregnancy trial. Am J Obstet Gynecol. 2023;229:516-521. PMID 37263400 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Gemechu KS, et al. Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis. Womens Health (Lond). 2020;16:1745506520973105. PMID 33334273 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Hadizadeh S, et al. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis. Arch Gynecol Obstet. 2024;309:929-937. PMID 37792010 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Hu H, et al. eHealth and Hypertensive Disorders of Pregnancy: Systematic Review. J Med Internet Res. 2025;27:e77064. PMID 40929717 — tags: [hypertension, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Hup RJ, et al. Oral antihypertensive treatment during pregnancy: a systematic review and network meta-analysis. Am J Obstet Gynecol. 2025;233:250-262. PMID 40216176 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Kazmi N, et al. Hypertensive Disorders of Pregnancy and DNA Methylation in Newborns. Hypertension. 2019;74:375-383. PMID 31230546 — tags: [hypertension, meta-analysis, review] — cited by: wiki/hypertension-in-pregnancy.md
• Kitt J, et al. Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial. JAMA. 2023;330:1991-1999. PMID 37950919 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, wiki/hypertension-in-pregnancy.md
• Kitt J, et al. Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Substudy. Circulation. 2024;149:529-541. PMID 37950907 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Kitt J, et al. Impact of Blood Pressure Self-Management on Vascular Remodeling After Hypertensive Pregnancy. Hypertension. 2025;82:1938-1947. PMID 40905148 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Magee LA, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407-17. PMID 25629739 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Magee LA, et al. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG. 2016;123:1135-41. PMID 26259808 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Magee LA, et al. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?. Hypertension. 2016;68:1153-1159. PMID 27620393 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Martin SL, et al. Effects of Antihypertensive Therapy During Pregnancy on Postpartum Blood Pressure Control. Obstet Gynecol. 2024;144:536-542. PMID 39265175 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Metoki H, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45:1298-1309. PMID 35726086 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Metz TD, et al. Optimal Timing of Delivery for Pregnant Individuals With Mild Chronic Hypertension. Obstet Gynecol. 2024;144:386-393. PMID 39013178 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Moore MD, et al. Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension. Obstet Gynecol. 2024;144:101-108. PMID 38781591 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Mussarat N, et al. Masked pregnancy-associated hypertension as a predictor of adverse outcomes. Am J Obstet Gynecol MFM. 2023;5:100976. PMID 37098390 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Pels A, et al. Influence of Gestational Age at Initiation of Antihypertensive Therapy: Secondary Analysis of CHIPS Trial Data (Control of Hypertension in Pregnancy Study). Hypertension. 2018;71:1170-1177. PMID 29686009 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Pooh RK. First-trimester preterm preeclampsia prediction model for prevention with low-dose aspirin. J Obstet Gynaecol Res. 2024;50:793-799. PMID 38366809 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Poon LC, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145 Suppl 1:1-33. PMID 31111484 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, wiki/hypertension-in-pregnancy.md
• Rajkumar T, et al. Remote blood pressure monitoring in women at risk of or with hypertensive disorders of pregnancy: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2025;169:89-104. PMID 39611763 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Rolnik DL, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50:492-495. PMID 28741785 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy. Am J Obstet Gynecol. 2024;231:342.e1-342.e9. PMID 38151219 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Rolnik DL, et al. Aspirin, Birthweight, and Large-For-Gestational-Age Neonates: A Secondary Analysis of the ASPRE Trial. BJOG. 2025;132:1606-1614. PMID 40590060 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Rolnik DL, et al. Combined impact of first-trimester risk and aspirin adherence on preterm preeclampsia prevention. Am J Obstet Gynecol. 2026;234:1759-1767. PMID 41707896 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Sanusi AA, et al. Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024;144:126-134. PMID 38949541 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Sanusi AA, et al. Clinical Trials That Have Changed Obstetric Practice: The Chronic Hypertension and Pregnancy (CHAP) Trial. Clin Obstet Gynecol. 2024;67:411-417. PMID 38465909 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Schliep KC, et al. Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis. Hypertension. 2023;80:257-267. PMID 36345823 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Shen L, et al. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis. Ultrasound Obstet Gynecol. 2021;58:546-552. PMID 33998099 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Tan MY, et al. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. Ultrasound Obstet Gynecol. 2018;52:52-59. PMID 29704277 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Tita AT, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022;386:1781-1792. PMID 35363951 — tags: [hypertension, rct] — cited by: wiki/hypertension-in-pregnancy.md
• Tol ID, et al. Postpartum management of the hypertensive disorders of pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2026;234:1593-1603. PMID 41421750 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertension-in-pregnancy.md
• Tranquilli AL, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4:97-104. PMID 26104417 — tags: [hypertension, primary] — cited by: literature/guidelines/REGISTRY.md, wiki/hypertension-in-pregnancy.md
• Vogel B, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397:2385-2438. PMID 34010613 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• von Dadelszen P, et al. Terminal Digit Preference and Threshold Avoidance in Digital Blood Pressure Measurements During Pregnancy: Secondary Analysis of Data From the CLIP and PRECISE Cohorts. JMIR Mhealth Uhealth. 2026;14:e73307. PMID 42234864 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md
• Walker SP, et al. Ambulatory blood pressure monitoring in pregnancy. Obstet Gynecol Surv. 1998;53:636-44. PMID 9793940 — tags: [hypertension, review] — cited by: wiki/hypertension-in-pregnancy.md
• Wang G, et al. Investigating a Potential Causal Relationship Between Maternal Blood Pressure During Pregnancy and Future Offspring Cardiometabolic Health. Hypertension. 2022;79:170-177. PMID 34784738 — tags: [hypertension, primary] — cited by: wiki/hypertension-in-pregnancy.md

Special populations

• Agarwal R. Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension. 2009;54:241-7. PMID 19528362 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Agarwal R, et al. Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol. 2009;30:126-34. PMID 19246891 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Anderson TS, et al. Intensification of older adults' outpatient blood pressure treatment at hospital discharge: national retrospective cohort study. BMJ. 2018;362:k3503. PMID 30209052 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Bansal N, et al. Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial. Am J Kidney Dis. 2021;77:12-22. PMID 32800842 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Bloch MJ, et al. African American patients with hypertensive chronic kidney disease receive no benefit on kidney disease progression from the currently recommended blood pressure goal of <130/80 mm Hg unless there is significant proteinuria at baseline: long-term follow-up of the AASK study. J Clin Hypertens (Greenwich). 2011;13:214-6. PMID 21366854 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Carr M, et al. Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial. Trials. 2026;27. PMID 41689048 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/clinical-trials-landscape.md, wiki/special-populations.md
• Dave CV, et al. Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents. JAMA Intern Med. 2024;184:661-669. PMID 38648065 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Fujiwara T, et al. Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study. PLoS Med. 2025;22:e1004731. PMID 40961130 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Georgianos PI, et al. Blood pressure control in conventional hemodialysis. Semin Dial. 2018;31:557-562. PMID 30084190 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Juraschek SP, et al. Effects of Antihypertensive Deprescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results From TONE. Am J Hypertens. 2022;35:337-346. PMID 34718403 — tags: [hypertension, rct] — cited by: wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Korogiannou M, et al. Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients. Am J Nephrol. 2021;52:548-558. PMID 34311458 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Liu W, et al. Central versus ambulatory blood pressure for predicting mortality and cardiovascular events in hemodialysis patients: a multicenter cohort study. J Hypertens. 2022;40:180-188. PMID 34433762 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Mainieri F, et al. Treatment of Hypertension in Children. Curr Hypertens Rev. 2024;20:80-89. PMID 39051576 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Mann JFE, et al. Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Curr Cardiol Rep. 2021;23:132. PMID 34398316 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Marcucci M, et al. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial. Ann Intern Med. 2023;176:605-614. PMID 37094336 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Martínez E, et al. Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial. Lancet HIV. 2026;13:e327-e337. PMID 42067280 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Mayer CC, et al. Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation. J Am Soc Nephrol. 2018;29:2409-2417. PMID 30045925 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Miskulin DC, et al. Blood Pressure Management in Hemodialysis Patients: What We Know And What Questions Remain. Semin Dial. 2017;30:203-212. PMID 28264150 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Norris K, et al. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006;48:739-51. PMID 17059993 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Ou-Yang H, et al. Inflammation markers and the risk of hypertension in people living with HIV. Front Immunol. 2023;14:1133640. PMID 37025998 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Park CH, et al. The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD. J Intern Med. 2023;294:653-664. PMID 37538023 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Raddaoui Y, et al. Role of depression in blood pressure control. A cross-sectional multicentric study. Tunis Med. 2024;102:7-12. PMID 38545723 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Santi M, et al. Arterial hypertension in children. Curr Opin Cardiol. 2015;30:403-10. PMID 26049390 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• See EJ, et al. Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease. Nephrology (Carlton). 2025;30:e14414. PMID 39725407 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Seeman T, et al. Unattended automated office blood pressure measurement in children. Blood Press. 2021;30:359-366. PMID 34565278 — tags: [hypertension, primary] — cited by: wiki/special-populations.md
• Sheppard JP, et al. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial. JAMA. 2020;323:2039-2051. PMID 32453368 — tags: [hypertension, rct] — cited by: OPEN-QUESTIONS.md, literature/patient-voice/sources.md, wiki/patient-experience-and-advocacy.md, wiki/red-flags-and-safety-concerns.md, wiki/special-populations.md
• Stergiou GS, et al. Accuracy of Automated Blood Pressure Measurement in Children: Evidence, Issues, and Perspectives. Hypertension. 2017;69:1000-1006. PMID 28438903 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Tada K, et al. Evaluating blood pressure targets in chronic kidney disease: a systematic review and meta-analysis. Hypertens Res. 2025;48:2358-2367. PMID 40542174 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/special-populations.md
• Theofilis P, et al. Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic Hypertension. Am J Nephrol. 2023;54:200-207. PMID 37231809 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• van Zoest RA, et al. Hypertension in people living with HIV. Curr Opin HIV AIDS. 2017;12:513-522. PMID 28787286 — tags: [hypertension, review] — cited by: wiki/special-populations.md
• Wright JT Jr, et al. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med. 2002;162:1636-43. PMID 12123409 — tags: [hypertension, rct] — cited by: wiki/special-populations.md
• Writing Committee Members, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;154:e50-e158. PMID 42263157 — tags: [hypertension, guideline, review] — cited by: literature/guidelines/REGISTRY.md, wiki/special-populations.md

Adherence, implementation and health systems

• Blyler CA, et al. Sustainability of blood pressure reduction in black barbershops. Curr Opin Cardiol. 2019;34:693-699. PMID 31425171 — tags: [hypertension, review] — cited by: wiki/adherence-and-implementation.md
• Bray EP, et al. Performance and persistence of a blood pressure self-management intervention: telemonitoring and self-management in hypertension (TASMINH2) trial. J Hum Hypertens. 2015;29:436-41. PMID 25566874 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Bryant KB, et al. It's Time for a Haircut: a Perspective on Barbershop Health Interventions Serving Black Men. J Gen Intern Med. 2020;35:3057-3059. PMID 32180133 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Bulto LN, et al. Effectiveness of nurse-led interventions versus usual care to manage hypertension and lifestyle behaviour: a systematic review and meta-analysis. Eur J Cardiovasc Nurs. 2024;23:21-32. PMID 37130339 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• da Luz Pádua Guimarães MC, et al. Prevalence of adherence to antihypertensive treatment: a comparison of drug biochemical analysis and the self-report scale. Clin Hypertens. 2026;32:e37. PMID 42564271 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Ebinger J, et al. Barbershop Management of Hypertension in the African American Population: Pitfalls and Opportunities for Extension to Other Underserved Communities. Curr Cardiol Rep. 2020;22:64. PMID 32562103 — tags: [hypertension, review] — cited by: wiki/adherence-and-implementation.md
• Gimbel S, et al. Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial. Implement Sci. 2020;15:15. PMID 32143657 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Grant S, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. 2019;69:e612-e620. PMID 31262847 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/adherence-and-implementation.md, wiki/patient-experience-and-advocacy.md
• Gupta P, et al. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). Eur J Heart Fail. 2021;23:1182-1190. PMID 33759308 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Hynes CA, et al. Medication Adherence in the Real World: Lessons from the Diuretic Comparison Project. J Clin Med. 2025;14. PMID 40869531 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Jacob V, et al. Economics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic Review. Am J Prev Med. 2015;49:772-783. PMID 26477804 — tags: [hypertension, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Jacob V, et al. Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review. Am J Prev Med. 2017;53:e105-e113. PMID 28818277 — tags: [hypertension, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Jacob V, et al. Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic Review. Am J Prev Med. 2023;65:735-754. PMID 37121447 — tags: [hypertension, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Joseph P, et al. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet. 2021;398:1133-1146. PMID 34469765 — tags: [hypertension, primary] — cited by: literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md
• Jubayer S, et al. Text messaging to improve retention in hypertension care in Bangladesh. J Hum Hypertens. 2024;38:765-771. PMID 39182005 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Kaambwa B, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol. 2014;21:1517-30. PMID 23990660 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Kassavou A, et al. The Association Between Smartphone App-Based Self-monitoring of Hypertension-Related Behaviors and Reductions in High Blood Pressure: Systematic Review and Meta-analysis. JMIR Mhealth Uhealth. 2022;10:e34767. PMID 35819830 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Kohrman N, et al. A qualitative analysis of post-hoc interviews with multilevel participants of a randomized controlled trial of a community-based intervention. PLoS One. 2024;19:e0303075. PMID 38723012 — tags: [hypertension, rct] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/adherence-and-implementation.md, wiki/patient-experience-and-advocacy.md
• Kulkarni S, et al. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study. Medicine (Baltimore). 2021;100:e24654. PMID 33832064 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md
• Monahan M, et al. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4). Hypertension. 2019;73:1231-1239. PMID 31067190 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Morris EC, et al. The importance of experience: insights into optimal home-blood pressure monitoring regimens from the TASMINH4 Trial. J Hypertens. 2025;43:1400-1406. PMID 40407130 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Njie GJ, et al. Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review. Prev Chronic Dis. 2015;12:E208. PMID 26605708 — tags: [hypertension, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Piette JD, et al. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006;59:739-46. PMID 16765278 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/adherence-and-implementation.md, wiki/patient-experience-and-advocacy.md
• Proia KK, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86-99. PMID 24933494 — tags: [hypertension, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md
• Reddy RV, et al. Cost-related medication nonadherence in adults with hypertension in the USA: implications for healthcare quality. Int J Qual Health Care. 2025;37. PMID 40285540 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/adherence-and-implementation.md, wiki/patient-experience-and-advocacy.md
• Rose F, et al. How often should self-monitoring of blood pressure be repeated? A secondary analysis of data from two randomized controlled trials. J Hypertens. 2025;43:1863-1870. PMID 40838357 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Santschi V, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718. PMID 24721801 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Stephen C, et al. Nurse-led interventions to manage hypertension in general practice: A systematic review and meta-analysis. J Adv Nurs. 2022;78:1281-1293. PMID 35244944 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/adherence-and-implementation.md
• Victor RG, et al. Sustainability of Blood Pressure Reduction in Black Barbershops. Circulation. 2019;139:10-19. PMID 30592662 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md
• Wallbach M, et al. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department. J Clin Hypertens (Greenwich). 2019;21:55-63. PMID 30515967 — tags: [hypertension, primary] — cited by: wiki/adherence-and-implementation.md, wiki/hypertensive-emergencies.md
• Wang J, et al. Understanding Gaps in the Hypertension and Diabetes Care Cascade: Systematic Scoping Review. JMIR Public Health Surveill. 2024;10:e51802. PMID 38149840 — tags: [hypertension, review] — cited by: wiki/adherence-and-implementation.md
• Yusuf S, et al. Polypill with or without Aspirin in Persons without Cardiovascular Disease. N Engl J Med. 2021;384:216-228. PMID 33186492 — tags: [hypertension, rct] — cited by: wiki/adherence-and-implementation.md

Hypertensive emergencies and acute care

• Aggarwal M, et al. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135-46. PMID 16326263 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Ando Y, et al. Posterior Reversible Encephalopathy Syndrome: A Review of the Literature. Intern Med. 2022;61:135-141. PMID 34275982 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Boulestreau R, et al. Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2024;83:1688-1701. PMID 38658108 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md
• Brody AM, et al. Institutional Pathways to Improve Care of Patients with Elevated Blood Pressure in the Emergency Department. Curr Hypertens Rep. 2018;20:30. PMID 29637311 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Carandini T, et al. Intensive versus standard lowering of blood pressure in the acute phase of intracranial haemorrhage: a systematic review and meta-analysis. Intern Emerg Med. 2018;13:95-105. PMID 28776173 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertensive-emergencies.md
• Collins S, et al. Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction. Curr Hypertens Rep. 2018;20:9. PMID 29478124 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Cremer A, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens. 2016;30:463-6. PMID 26582411 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• El-Ghoroury H, et al. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?. J Stroke Cerebrovasc Dis. 2021;30:105959. PMID 34217067 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Feldstein C. Management of hypertensive crises. Am J Ther. 2007;14:135-9. PMID 17414580 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Fischer M, et al. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264:1608-1616. PMID 28054130 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Frei SP, et al. Frequency of serious outcomes in patients with hypertension as a chief complaint in the emergency department. J Am Osteopath Assoc. 2013;113:664-8. PMID 24005086 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Gewirtz AN, et al. Posterior Reversible Encephalopathy Syndrome. Curr Pain Headache Rep. 2021;25:19. PMID 33630183 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Halbach SM, et al. Posterior Reversible Encephalopathy Syndrome in Children and Adolescents. Curr Hypertens Rep. 2024;26:349-354. PMID 38727870 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Ipek E, et al. Hypertensive crisis: an update on clinical approach and management. Curr Opin Cardiol. 2017;32:397-406. PMID 28306673 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Jacobs ZG, et al. Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative. J Hosp Med. 2019;14:144-150. PMID 30811319 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Jeelani H, et al. Posterior Reversible Encephalopathy Syndrome in Organ Transplantation. Exp Clin Transplant. 2022;20:642-648. PMID 35924741 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Kotruchin P, et al. Hypertensive emergencies in Asia: A brief review. J Clin Hypertens (Greenwich). 2022;24:1226-1235. PMID 36196470 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Li Y, et al. Posterior reversible encephalopathy syndrome and autoimmunity. Autoimmun Rev. 2023;22:103239. PMID 36464226 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Lipari M, et al. As-needed intravenous antihypertensive therapy and blood pressure control. J Hosp Med. 2016;11:193-8. PMID 26560085 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Ma H, et al. Clinical value of multiorgan damage in hypertensive crises: A prospective follow-up study. J Clin Hypertens (Greenwich). 2020;22:914-923. PMID 32271999 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Murali S, et al. Preeclampsia, eclampsia, and posterior reversible encephalopathy syndrome. Handb Clin Neurol. 2020;172:63-77. PMID 32768095 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Nahle T, et al. Inpatient Admissions for Hypertensive Crises in the USA by Race and Gender: A Retrospective Study From the National Inpatient Sample From 2016 to 2022. J Clin Hypertens (Greenwich). 2026;28:e70207. PMID 41543283 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Nonaka K, et al. Clinical and pathological evaluation of hypertensive emergency-related nephropathy. Intern Med. 2013;52:45-53. PMID 23291673 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Ona DID, et al. Executive Summary of the 2024 Philippine Clinical Practice Guidelines on the Diagnosis and Management of Acute Severe Blood Pressure Elevation. J Clin Hypertens (Greenwich). 2026;28:e70199. PMID 41614648 — tags: [hypertension, guideline] — cited by: literature/guidelines/REGISTRY.md, wiki/hypertensive-emergencies.md
• Pak KJ, et al. Acute hypertension: a systematic review and appraisal of guidelines. Ochsner J. 2014;14:655-63. PMID 25598731 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Patel KK, et al. Characteristics and Outcomes of Patients Presenting With Hypertensive Urgency in the Office Setting. JAMA Intern Med. 2016;176:981-8. PMID 27294333 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md, wiki/red-flags-and-safety-concerns.md
• Reis KG, et al. Hypertensive Urgency in Tanzanian Adults: A 1-Year Prospective Study. Am J Hypertens. 2020;33:1087-1091. PMID 32776154 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Sterpi AE, et al. Blood Pressure Control With Clevidipine Is Associated With Hematoma Volume Reduction in Acute Hypertensive Intracerebral Hemorrhage: A Single-Center Prospective Cohort Study. Eur J Neurol. 2026;33:e70689. PMID 42397158 — tags: [hypertension, primary] — cited by: wiki/hypertensive-emergencies.md
• Strauss M, et al. [The hypertensive emergency situation : Recommendations for initial drug therapy management]. Med Klin Intensivmed Notfmed. 2022;117:41-48. PMID 32940723 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Triplett JD, et al. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol. 2022;22:183-189. PMID 35046115 — tags: [hypertension, review] — cited by: wiki/hypertensive-emergencies.md
• Zhang K, et al. Intensive Versus Standard Blood Pressure Management after Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review and Meta-analysis. J Neurosurg Anesthesiol. 2025;37:20-30. PMID 38557945 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: wiki/hypertensive-emergencies.md

Safety, adverse events and over-treatment

• Adelborg K, et al. Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study. PLoS One. 2019;14:e0218739. PMID 31226134 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md
• Gregg LP, et al. Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders?. Nephrol Dial Transplant. 2023;38:1355-1365. PMID 36264349 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md
• Juraschek SP, et al. Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis. Ann Intern Med. 2021;174:58-68. PMID 32909814 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/statistics/STATISTICS.md, wiki/red-flags-and-safety-concerns.md
• Juraschek SP, et al. Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis. BMJ. 2025;388:e080507. PMID 40132860 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/statistics/STATISTICS.md, wiki/red-flags-and-safety-concerns.md
• Laham E. [Withdrawal effects following interruption of antihypertensive drugs. II. Coronary rebound phenomenon with antihypertensive drugs used in coronary heart disease therapy (author's transl)]. Sem Hop. 1979;55:1905-8. PMID 231311 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md
• Pandey AK, et al. Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. Eur Heart J. 2022;43:2931-2945. PMID 35713973 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md
• Raebel MA, et al. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med. 2010;25:326-33. PMID 20087674 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md
• Rajesh S, et al. A Review of Clinical Trial and Meta-Analyses of BP Treatment Strategies for Patients with Orthostatic Hypotension: Blood Pressure Management in Patients with Hypertension and Orthostatic Hypotension. Curr Hypertens Rep. 2026;28. PMID 42033492 — tags: [hypertension, meta-analysis, review] — cited by: wiki/red-flags-and-safety-concerns.md
• Strauss FG, et al. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension. JAMA. 1977;238:1734-6. PMID 578267 — tags: [hypertension, primary] — cited by: wiki/red-flags-and-safety-concerns.md

Clinical trials landscape and protocols

• Böhm M, et al. Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Clin Res Cardiol. 2020;109:289-302. PMID 32034481 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Chow CK, et al. Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol. Am Heart J. 2021;231:56-67. PMID 33017580 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Danaietash P, et al. Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan. J Clin Hypertens (Greenwich). 2022;24:804-813. PMID 35686330 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md
• Flack JM, et al. Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24. Hypertens Res. 2025;48:2911-2923. PMID 40850955 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Franssen M, et al. Telemonitoring and/or self-monitoring of blood pressure in hypertension (TASMINH4): protocol for a randomised controlled trial. BMC Cardiovasc Disord. 2017;17:58. PMID 28193176 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md
• Ishani A, et al. Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project. Contemp Clin Trials. 2022;116:106754. PMID 35390512 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Joseph P, et al. The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct. Am Heart J. 2018;206:72-79. PMID 30342297 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Kandzari DE, et al. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J. 2016;171:82-91. PMID 26699604 — tags: [hypertension, review] — cited by: wiki/clinical-trials-landscape.md
• Li KC, et al. Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS). BMJ Open. 2021;11:e045929. PMID 34285006 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Mauri L, et al. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Am Heart J. 2018;195:115-129. PMID 29224639 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md
• Salam A, et al. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. Am Heart J. 2014;167:127-32. PMID 24439972 — tags: [hypertension, rct] — cited by: wiki/clinical-trials-landscape.md
• Sheppard JP, et al. OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial. BMJ Open. 2018;8:e022930. PMID 30287610 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md
• Sun Y, et al. Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in China. Am J Hypertens. 2021;34:831-839. PMID 33605981 — tags: [hypertension, primary] — cited by: wiki/clinical-trials-landscape.md

Patient experience and qualitative research

• Abdul Wahab NA, et al. Exploring Culture, Religiosity and Spirituality Influence on Antihypertensive Medication Adherence Among Specialised Population: A Qualitative Ethnographic Approach. Patient Prefer Adherence. 2021;15:2249-2265. PMID 34675490 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Abel WM, et al. Antihypertensive medication adherence and persistence among Black women: A qualitative study. Nurse Pract. 2022;47:40-47. PMID 35171867 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Al-Bayan M, et al. Neighborhood perceptions and hypertension among low-income black women: a qualitative study. BMC Public Health. 2016;16:1075. PMID 27733142 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Ayodele V, et al. Managing Blood Pressure Beyond Viral Suppression for Patient and Provider Perspectives on Antihypertensive Medication Adherence in HIV Care: A Qualitative Study. Res Sq. 2026. PMID 42239779 — tags: [hypertension, preprint] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Bane C, et al. The journey to concordance for patients with hypertension: a qualitative study in primary care. Pharm World Sci. 2007;29:534-40. PMID 17487567 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Baratta J, et al. Patient and Health Professional Perceptions of Telemonitoring for Hypertension Management: Qualitative Study. JMIR Form Res. 2022;6:e32874. PMID 35687380 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Basu S, et al. Determinants of adherence to antihypertensive treatment among patients attending a primary care clinic with limited medical armamentarium in Delhi, India: A qualitative study. Chronic Illn. 2022;18:295-305. PMID 32938210 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Edward A, et al. Patient and healthcare provider perspectives on adherence with antihypertensive medications: an exploratory qualitative study in Tanzania. BMC Health Serv Res. 2021;21:834. PMID 34407820 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Ghai I, et al. Barriers and facilitators of habit building for long-term adherence to antihypertensive therapy among people with hypertensive disorders in Los Angeles, California: a qualitative study. BMJ Open. 2024;14:e079401. PMID 38991671 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Gupta S, et al. Qualitative Study of Barriers to Adherence to Antihypertensive Medication among Rural Women in India. Int J Hypertens. 2019;2019:5749648. PMID 30809390 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Johnston ME, et al. Effects of labelling on income, work and social function among hypertensive employees. J Chronic Dis. 1984;37:417-23. PMID 6725496 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Li Q, et al. Physical activity experience of patients with hypertension: a systematic review and synthesis of qualitative literature. BMC Public Health. 2024;24:2826. PMID 39407187 — tags: [hypertension, systematic-review, review] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• M Yatim H, et al. Factors influencing patients' hypertension self-management and sustainable self-care practices: a qualitative study. Public Health. 2019;173:5-8. PMID 31207425 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Malkon S, et al. A Qualitative Study on Patients' Views on Hypertension and Antihypertensive Medications. Patient Prefer Adherence. 2023;17:3331-3339. PMID 38106370 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Mondesir FL, et al. Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors. Patient Prefer Adherence. 2019;13:2017-2027. PMID 31819383 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, wiki/patient-experience-and-advocacy.md
• Najjuma JN, et al. Adherence to Antihypertensive Medication: An Interview Analysis of Southwest Ugandan Patients' Perspectives. Ann Glob Health. 2020;86:58. PMID 32897274 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Natale P, et al. Perspectives and Experiences of Self-monitoring of Blood Pressure Among Patients With Hypertension: A Systematic Review of Qualitative Studies. Am J Hypertens. 2023;36:372-384. PMID 36840919 — tags: [hypertension, systematic-review, review] — cited by: OPEN-QUESTIONS.md, literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Oyibo P, et al. Barriers and Enablers of Antihypertensive Adherence Among a Nigerian Adult Hypertensive Population Seeking Care in Public Secondary Health Facilities in Delta State, Nigeria: A Mixed Methods Study. West Afr J Med. 2025;42:240-247. PMID 40845429 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Rahmawati R, et al. Understanding untreated hypertension from patients' point of view: A qualitative study in rural Yogyakarta province, Indonesia. Chronic Illn. 2018;14:228-240. PMID 28669227 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Sandeep M, et al. Prevalence of Non-Adherence to Antihypertensive Medication in India: A Systematic Review and Meta-Analysis of 18,808 Hypertensive Patients. Curr Hypertens Rev. 2025;21:231-246. PMID 40926604 — tags: [hypertension, meta-analysis, systematic-review, review] — cited by: literature/patient-voice/sources.md, wiki/patient-experience-and-advocacy.md
• Shamsi A, et al. Life experiences of patients before having hypertension: a qualitative study. Electron Physician. 2017;9:3925-3933. PMID 28461866 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Singh K, et al. Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study. BMJ Open. 2021;11:e048926. PMID 34145019 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Strandberg S, et al. Self-care management and experiences of using telemonitoring as support when living with hypertension or heart failure: A descriptive qualitative study. Int J Nurs Stud Adv. 2023;5:100149. PMID 38746569 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Tsiantou V, et al. Factors affecting adherence to antihypertensive medication in Greece: results from a qualitative study. Patient Prefer Adherence. 2010;4:335-43. PMID 20859460 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• van Bussel E, et al. Hypertension management: experiences, wishes and concerns among older people-a qualitative study. BMJ Open. 2019;9:e030742. PMID 31427342 — tags: [hypertension, primary] — cited by: OPEN-QUESTIONS.md, literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• Yogarajah N, et al. Exploring adherence to antihypertensive medication in Black African and Black Caribbean residents in South East London: a qualitative study. BJGP Open. 2025;9. PMID 40389279 — tags: [hypertension, primary] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md

Audit-added records — 2026-09-01

• Benetos A, et al. Reduction of Antihypertensive Treatment in Nursing Home Residents. N Engl J Med. 2025;393:1990-2000. PMID 40879421 — tags: [hypertension, randomized-trial, deprescribing, frailty] — cited by: wiki/clinical-trials-landscape.md, wiki/special-populations.md
• Egan BM, et al. Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016;29:976-983. PMID 27076600 — tags: [hypertension, randomized-trial, renin, resistant-hypertension] — cited by: wiki/clinical-trials-landscape.md, wiki/resistant-and-refractory-hypertension.md, wiki/secondary-hypertension.md
• Singhal K, et al. A parallel-arm randomised control trial to study the effects of risk communication methods for prevention of cardiovascular diseases: EFFRICO trial. J Family Med Prim Care. 2024;13:1922-1930. PMID 38948564 — tags: [hypertension, randomized-trial, risk-communication] — cited by: literature/patient-voice/sources.md, wiki/patient-experience-and-advocacy.md
• Merabtine A, et al. Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA). BMJ Open. 2025;15:e111167. PMID 41419284 — tags: [hypertension, trial-protocol, renin, primary-aldosteronism] — cited by: wiki/clinical-trials-landscape.md, wiki/secondary-hypertension.md
• Di M, et al. Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial. BMJ Evid Based Med. 2020;25:102-108. PMID 31473598 — tags: [hypertension, randomized-trial, risk-communication, adherence] — cited by: literature/patient-voice/sources.md, literature/patient-voice/themes.md, wiki/patient-experience-and-advocacy.md
• He J, et al. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial. Lancet. 2023;401:928-938. PMID 36871573 — tags: [hypertension, randomized-trial, implementation, cardiovascular-outcomes] — cited by: literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md
• Sun G, et al. Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial. Circulation. 2026. PMID 42666029 — tags: [hypertension, randomized-trial, implementation, cardiovascular-outcomes] — cited by: literature/notes/sun-2022-village-doctor.md, literature/statistics/STATISTICS.md, wiki/adherence-and-implementation.md
• Easterling T, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394:1011-1021. PMID 31378394 — tags: [hypertension, pregnancy, randomized-trial] — cited by: wiki/hypertension-in-pregnancy.md
• Lovgren T, et al. Impact of labetalol versus nifedipine treatment on readmission risk in postpartum hypertension: A randomized controlled trial. Pregnancy (Hoboken). 2025;1:e70005. PMID 42597172 — tags: [hypertension, postpartum, randomized-trial] — cited by: wiki/hypertension-in-pregnancy.md